Cover Page
Cover Page - USD ($) $ in Millions | 12 Months Ended | ||
Jun. 27, 2020 | Sep. 04, 2020 | Dec. 28, 2019 | |
Cover [Abstract] | |||
Document Type | 10-K | ||
Document Annual Report | true | ||
Document Period End Date | Jun. 27, 2020 | ||
Document Transition Report | false | ||
Entity File Number | 0-11559 | ||
Entity Registrant Name | KEY TRONIC CORP | ||
Entity Incorporation, State or Country Code | WA | ||
Entity Tax Identification Number | 91-0849125 | ||
Entity Address, Address Line One | 4424 North Sullivan Road | ||
Entity Address, City or Town | Spokane Valley, | ||
Entity Address, State or Province | WA | ||
Entity Address, Postal Zip Code | 99216 | ||
City Area Code | 509 | ||
Local Phone Number | 928-8000 | ||
Title of 12(b) Security | Common stock, no par value | ||
Trading Symbol | KTCC | ||
Security Exchange Name | NASDAQ | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Accelerated Filer | ||
Entity Small Business | true | ||
Entity Emerging Growth Company | false | ||
ICFR Auditor Attestation Flag | true | ||
Entity Shell Company | false | ||
Entity Public Float | $ 56.7 | ||
Entity Common Stock, Shares Outstanding | 10,759,680 | ||
Documents Incorporated by Reference | Certain information is incorporated into Part III of this report by reference to the Proxy Statement for the registrant’s 2020 annual meeting of stockholders to be filed with the Securities and Exchange Commission pursuant to Regulation 14A not later than 120 days after the end of the fiscal year covered by this Form 10-K. | ||
Amendment Flag | false | ||
Document Fiscal Year Focus | 2020 | ||
Document Fiscal Period Focus | FY | ||
Current Fiscal Year End Date | --06-27 | ||
Entity Central Index Key | 0000719733 |
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED BALANCE SHEETS - USD ($) | Jun. 27, 2020 | Jun. 29, 2019 |
Current assets: | ||
Cash and cash equivalents | $ 553,000 | $ 601,000 |
Trade receivables, net of allowance for doubtful accounts of $609 and $58 | 86,123,000 | 58,429,000 |
Inventories, net | 115,020,000 | 100,431,000 |
Other | 17,315,000 | 16,477,000 |
Total current assets | 242,764,000 | 198,099,000 |
Property, plant and equipment, net | 31,764,000 | 29,413,000 |
Operating Lease, Right-of-Use Asset | 17,568,000 | 0 |
Other assets: | ||
Deferred income tax asset | 10,178,000 | 7,840,000 |
Other intangible assets, net | 0 | 657,000 |
Other | 2,587,000 | 2,301,000 |
Total other assets | 12,765,000 | 10,798,000 |
Total assets | 304,861,000 | 238,310,000 |
Current liabilities: | ||
Accounts payable | 80,204,000 | 73,571,000 |
Accrued compensation and vacation | 10,428,000 | 6,759,000 |
Current portion of debt, net | 7,508,000 | 5,841,000 |
Other | 14,079,000 | 7,233,000 |
Total current liabilities | 112,219,000 | 93,404,000 |
Long-term liabilities: | ||
Term loans | 3,258,000 | 7,091,000 |
Revolving loan | 60,094,000 | 23,356,000 |
Operating lease liabilities | 12,624,000 | 0 |
Deferred income tax liability | 234,000 | 0 |
Other long-term obligations | 875,000 | 0 |
Total long-term liabilities | 77,085,000 | 30,447,000 |
Total liabilities | 189,304,000 | 123,851,000 |
Commitments and contingencies (Note 4 and 9) | ||
Shareholders’ equity: | ||
Common stock, no par value—shares authorized 25,000; issued and outstanding 10,760 and 10,760 shares, respectively | 46,946,000 | 46,680,000 |
Retained earnings | 70,111,000 | 65,353,000 |
Accumulated other comprehensive (loss) income | (1,500,000) | 2,426,000 |
Total shareholders’ equity | 115,557,000 | 114,459,000 |
Total liabilities and shareholders’ equity | $ 304,861,000 | $ 238,310,000 |
CONSOLIDATED BALANCE SHEETS (Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands | Jun. 27, 2020 | Jun. 29, 2019 |
Statement of Financial Position [Abstract] | ||
Trade receivables, allowance for doubtful accounts | $ 609 | $ 58 |
Common stock - par value | $ 0 | $ 0 |
Common stock - shares authorized | 25,000,000 | 25,000,000 |
Common stock - issued | 10,760,000 | 10,760,000 |
Common stock - outstanding | 10,760,000 | 10,760,000 |
CONSOLIDATED STATEMENTS OF INCO
CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
Jun. 27, 2020 | Jun. 29, 2019 | Jun. 30, 2018 | |
Income Statement [Abstract] | |||
Revenues | $ 449,480 | $ 464,044 | $ 446,322 |
Cost of Goods and Services Sold | 414,231 | 429,443 | 412,153 |
Gross profit | 35,249 | 34,601 | 34,169 |
Operating expenses | |||
Research, development and engineering expenses | 7,391 | 6,555 | 6,186 |
Selling, general and administrative expenses | 21,030 | 21,556 | 22,334 |
Goodwill and intangible assets impairment | 0 | 12,448 | 0 |
Loss on settlement of arbitration | 0 | 0 | 4,535 |
Total operating expenses | 28,421 | 40,559 | 33,055 |
Operating income (loss) | 6,828 | (5,958) | 1,114 |
Interest expense, net | 2,509 | 2,782 | 2,556 |
Income (loss) before income taxes | 4,319 | (8,740) | (1,442) |
Income tax benefit | (439) | (758) | (117) |
Net income (loss) | $ 4,758 | $ (7,982) | $ (1,325) |
Earnings per share: | |||
Net income (loss) per share — Basic | $ 0.44 | $ (0.74) | $ (0.12) |
Weighted average shares outstanding– basic | 10,760 | 10,760 | 10,760 |
Net income (loss) per share — Diluted | $ 0.44 | $ (0.74) | $ (0.12) |
Weighted average shares outstanding — Diluted | 10,816 | 10,760 | 10,760 |
CONSOLIDATED STATEMENTS OF COMP
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 27, 2020 | Jun. 29, 2019 | Jun. 30, 2018 | |
Comprehensive income (loss): | |||
Net income (loss) | $ 4,758 | $ (7,982) | $ (1,325) |
Other comprehensive income (loss): | |||
Unrealized gain (loss) on hedging instruments, net of tax | (3,926) | 3,395 | 2,392 |
Comprehensive income (loss) | $ 832 | $ (4,587) | $ 1,067 |
CONSOLIDATED STATEMENTS OF CO_2
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) - USD ($) $ in Millions | 12 Months Ended | ||
Jun. 27, 2020 | Jun. 29, 2019 | Jun. 30, 2018 | |
Statement of Comprehensive Income [Abstract] | |||
Unrealized gain (loss) on foreign exchange contracts, tax | $ (1.1) | $ 1 | $ 0.7 |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 27, 2020 | Jun. 29, 2019 | Jun. 30, 2018 | |
Operating activities: | |||
Net income (loss) | $ 4,758 | $ (7,982) | $ (1,325) |
Adjustments to reconcile net income (loss) to cash provided by (used in) operating activities: | |||
Goodwill and intangible assets impairment | 0 | 12,448 | 0 |
Depreciation and amortization | 5,591 | 7,298 | 7,774 |
Amortization of deferred loan costs | 30 | 30 | 30 |
Provision for obsolete inventory | 136 | 91 | 31 |
Provision for warranty | 121 | 83 | 74 |
Provision for (recovery of) doubtful accounts | 551 | 58 | (84) |
Loss on disposal of assets | 207 | 3 | 20 |
Share-based compensation expense | 266 | 436 | 447 |
Deferred income taxes | 958 | 1,116 | 1,562 |
Loss on settlement of arbitration | 0 | 0 | 4,535 |
Changes in operating assets and liabilities | |||
Trade receivables | (28,254) | 3,344 | (1,327) |
Contract assets | (1,592) | (10,255) | 0 |
Cash received from arbitration settlement | 0 | 6,684 | 0 |
Inventories | (14,725) | (1,417) | (18,101) |
Other assets | (7,728) | (4,490) | (10,461) |
Accounts payable | 6,632 | (2,627) | 22,920 |
Accrued compensation and vacation | 3,669 | (1,346) | (1,900) |
Other liabilities | 292 | (323) | 2,051 |
Cash provided by (used in) operating activities | (31,004) | 919 | 3,122 |
Investing activities: | |||
Purchases of property and equipment | (8,623) | (8,386) | (4,523) |
Proceeds from sale of fixed assets | 696 | 22 | 1,041 |
Cash receipts from deferred purchase price of factored receivables | 4,350 | 6,455 | 8,335 |
Cash provided by (used in) investing activities | (3,577) | (1,909) | 4,853 |
Financing activities: | |||
Payment of financing costs | (84) | (15) | (21) |
Proceeds from issuance of long term debt | 5,000 | 0 | 0 |
Repayments of long term debt | (7,121) | (5,871) | (5,871) |
Borrowings under revolving credit agreement | 177,343 | 181,688 | 187,419 |
Repayments of revolving credit agreement | (140,605) | (174,554) | (189,532) |
Cash provided by (used in) financing activities | 34,533 | 1,248 | (8,005) |
Net increase (decrease) in cash and cash equivalents | (48) | 258 | (30) |
Cash and cash equivalents, beginning of period | 601 | 343 | 373 |
Cash and cash equivalents, end of period | 553 | 601 | 343 |
Supplemental cash flow information: | |||
Interest payments | 2,483 | 2,773 | 2,529 |
Income tax payments, net of refunds | $ 683 | $ (511) | $ 304 |
CONSOLIDATED STATEMENTS OF SHAR
CONSOLIDATED STATEMENTS OF SHAREHOLDER'S EQUITY - USD ($) shares in Thousands, $ in Thousands | Total | Common Stock | Retained Earnings | Accumulated Other Comprehensive Income (Loss) |
Balances, beginning of period (Shares) at Jul. 01, 2017 | 10,760 | |||
Balances, beginning of period at Jul. 01, 2017 | $ 116,567 | $ 45,797 | $ 73,545 | $ (2,775) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||
Net income (loss) | (1,325) | (1,325) | ||
Tax rate effect reclassification | 586 | (586) | ||
Unrealized gain (loss) on foreign exchange contracts, net | 2,392 | 2,392 | ||
Share-based compensation expense | 447 | $ 447 | ||
Balances, end of period (Shares) at Jun. 30, 2018 | 10,760 | |||
Balances, end of period at Jun. 30, 2018 | 118,081 | $ 46,244 | 72,806 | (969) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||
Net income (loss) | (7,982) | (7,982) | ||
ASC 606 opening balance sheet adjustment | 529 | 529 | ||
Unrealized gain (loss) on foreign exchange contracts, net | 3,395 | 3,395 | ||
Share-based compensation expense | 436 | $ 436 | ||
Balances, end of period (Shares) at Jun. 29, 2019 | 10,760 | |||
Balances, end of period at Jun. 29, 2019 | 114,459 | $ 46,680 | 65,353 | 2,426 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||
Net income (loss) | 4,758 | 4,758 | ||
Unrealized gain (loss) on foreign exchange contracts, net | (3,926) | (3,926) | ||
Share-based compensation expense | 266 | $ 266 | ||
Balances, end of period (Shares) at Jun. 27, 2020 | 10,760 | |||
Balances, end of period at Jun. 27, 2020 | $ 115,557 | $ 46,946 | $ 70,111 | $ (1,500) |
SIGNIFICANT ACCOUNTING POLICIES
SIGNIFICANT ACCOUNTING POLICIES | 12 Months Ended |
Jun. 27, 2020 | |
Accounting Policies [Abstract] | |
SIGNIFICANT ACCOUNTING POLICIES | SIGNIFICANT ACCOUNTING POLICIES Business Key Tronic Corporation and subsidiaries (the Company) is engaged in electronic manufacturing services (EMS) for original equipment manufacturers (OEMs) and also manufactures keyboards and other input devices. The Company’s headquarters are located in Spokane Valley, Washington with manufacturing operations in Oakdale, Minnesota; Fayetteville, Arkansas; Corinth, Mississippi; and foreign manufacturing operations in Juarez, Mexico; Shanghai, China; and Da Nang, Vietnam. The 2019 novel strain of coronavirus ("COVID-19") has resulted in business slowdowns or shutdowns in affected areas. In January 2020, the Company’s China facilities faced temporary shutdowns as a result of government mandates. In March 2020, these facilities began returning to full operation and the supply chain disruptions have been abating. In April 2020, the Company announced the temporary closure of its Juarez facilities, however, operations successfully resumed six days later. Due to the COVID-19 pandemic, the Company has seen extreme shifts in demand from its customer base. The possibility of future temporary closures, as well as adverse fluctuations in customer demand, freight and expedite costs, precautionary safety expenses, collectibility of accounts, and future supply chain disruptions during the rapidly changing COVID-19 environment can materially impact operating results. Additionally, continued adverse macroeconomic conditions and significant currency exchange fluctuations can also materially impact operating results. Reclassifications Certain prior period reclassifications were made to conform with the current period presentation. These reclassifications had no effect on reported income, comprehensive income, cash flows, total assets, or shareholders’ equity as previously reported. Principles of Consolidation The consolidated financial statements include the Company and its wholly owned subsidiaries in the United States, Mexico, China and Vietnam. Intercompany balances and transactions have been eliminated during consolidation. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Estimates include the allowance for doubtful receivables, the provision for obsolete and non-saleable inventories, deferred tax assets and liabilities, uncertain tax positions, valuation of goodwill, impairment of long-lived assets, medical self-funded insurance liability, long-term incentive compensation accrual, the provision for warranty costs, the fair value of stock appreciation rights granted under the Company’s share-based compensation plan and purchase price allocation of acquired businesses. Due to uncertainties with respect to the assumptions and estimates, actual results could differ from those estimates. Cash and Cash Equivalents The Company considers investments with an original maturity of three months or less to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value. The Company may have cash and cash equivalents at financial institutions that are in excess of federally insured limits from time to time. Allowance for Doubtful Accounts The Company evaluates the collectability of accounts receivable and records an allowance for doubtful accounts, which reduces the receivables to an amount that management reasonably estimates will be collected. A specific allowance is recorded against receivables considered to be impaired based on the Company’s knowledge of the financial condition of the customer. In determining the amount of the allowance, the Company considers several factors including the aging of the receivables, the current business environment and historical experience. After all attempts to collect a receivable have failed, the receivable is written off against the allowance. Inventories Inventories are stated at the lower of cost or net realizable value. Inventory valuation is determined using the first-in, first-out (FIFO) method. Customer orders are based upon forecasted quantities of product manufactured for shipment over defined periods. Raw material inventories are purchased to fulfill these customer requirements. Within these arrangements, customer demands for products frequently change, sometimes creating excess and obsolete inventories. The Company regularly reviews raw material inventories by customer for both excess and obsolete quantities. Wherever possible, the Company attempts to recover its full cost of excess and obsolete inventories from customers or, in some cases, through other markets. When it is determined that the Company’s carrying cost of such excess and obsolete inventories cannot be recovered in full, a charge is taken against income for the difference between the carrying cost and the estimated realizable amount. We also reserve for inventory related to specific customers covered by lead-time assurance agreements when those customers are experiencing financial difficulties or reimbursement is not reasonably assured. Property, Plant and Equipment Property, plant and equipment are carried at cost and depreciated using straight-line methods over the expected useful lives of the assets. Repairs and maintenance costs are expensed as incurred. Impairment of Goodwill In accordance with accounting guidance on goodwill and other intangible assets, the Company evaluates goodwill for impairment at the reporting unit level annually, and whenever circumstances occur indicating that goodwill might be impaired. Upon adoption of ASU 2017-04, the Company now recognizes an impairment charge (not to exceed the total amount of goodwill allocated to the reporting unit) for the amount by which the carrying amount of a reporting unit exceeds the reporting unit’s fair value. During the third quarter of fiscal year 2019, a few large programs declined in revenue and two new programs were delayed. This decrease in the Company’s total revenue combined with book value continuing to exceed market capitalization caused a “triggering event” in which to perform a quantitative impairment analysis as of March 30, 2019. To estimate the fair value of the Company’s equity, the Company used both a market approach and an income approach, based on a discounted cash flows analysis. As of March 30, 2019, market related factors increased expected required rates of return, which also increased the Company’s discount rate used to project future cash flows. Further, push outs of the Company’s forecasted future cash flows relating to delays in customer orders adversely impacted the Company’s discounted cash flows model. As a result, a lower estimate in the Company’s fair value using these two valuation methods indicated an impairment charge. During the third quarter of fiscal year 2019, the Company also assessed other finite-lived intangible assets including the Company’s customer relationships and favorable lease agreements due to an indicator of possible impairment being present, as discussed above. As a result of the analysis performed, the Company determined that the carrying value of the customer relationships intangible asset was not recoverable and recorded an impairment for the entire carrying amount during the third quarter of fiscal year 2019. The Company’s analysis did not indicate that any of its other long-lived assets were impaired. Refer to footnote 14 for impairment analysis for goodwill and other intangibles that occurred during fiscal year 2019, as a result of certain triggering events being present. Impairment of Long-lived Assets The Company, using its best estimates based on reasonable and supportable assumptions and projections, reviews assets for impairment whenever events or changes in circumstances have indicated that the carrying amount of its assets might not be recoverable. Impaired assets are reported at the lower of cost or fair value. Accrued Warranty An accrual is made for expected warranty costs, with the related expense recognized in cost of goods sold. Management reviews the adequacy of this accrual quarterly based on historical analyses and anticipated product returns. Self-funded Insurance The Company self-funds its domestic employee health plans. The Company contracts with a separate administrative service company to supervise and administer the programs and act as its representative. The Company reduces its risk under this self-funded platform by purchasing stop-loss insurance coverage for high dollar individual claims. In addition, if the aggregate annual claims amount to more than 125 percent of expected claims for the plan year this insurance will also pay those claims amounts exceeding that level. The Company estimates its exposure for claims incurred but not paid at the end of each reporting period and uses historical claims data supplied by the Company’s broker to estimate its self-funded insurance liability. This liability is subject to a total limitation that varies based on employee enrollment and factors that are established at each annual contract renewal. Actual claims experience may differ from the Company’s estimates. Costs related to the administration of the plan and related claims are expensed as incurred. Revenue Recognition Prior to the adoption of ASU 2014-09, Revenue from Contracts with Customers (Topic 606), sales revenue from manufacturing is recognized upon shipment of the manufactured product per contractual terms. Upon shipment, title transfers and the customer assumes risks and rewards of ownership of the product. The price to the buyer is fixed or determinable and recoverability is reasonably assured. Unless specifically stated in contractual terms, there are no formal customer acceptance requirements or further obligations related to the manufacturing services; if any such requirements exist, then sales revenue is recognized at the time when such requirements are completed and such obligations are fulfilled. Revenue is recorded net of estimated returns of manufactured product based on management’s analysis of historical returns. Subsequent to the adoption of ASU 2014-09, Revenue from Contracts with Customers (Topic 606) during the year ended June 29, 2019, the first step in its process for revenue recognition is to identify the contract with a customer. A contract is defined as an agreement between two or more parties that creates enforceable rights and obligations. A contract can be written, oral, or implied. The Company generally enters into manufacturing service agreements (“MSA”) with its customers that outlines the terms of the business relationship between the customer and the Company. This includes matters such as warranty, indemnification, transfer of title and risk of loss, liability for excess and obsolete inventory, pricing, payment terms, etc. The Company will also bid on a program-by-program basis for customers in which an executed MSA may not be in place. In these instances, as well as when we have an MSA in place, we receive customer purchase orders for specific quantities and timing of products. As a result, the Company considers its contract with a customer to be the combination of the MSA and the purchase order. The transaction price is fixed and set forth in each purchase order. In the Company's normal course of business, there are no variable pricing components, or material amounts refunded to customers in the form of refunds or rebates. The Company assesses whether control of the product or services promised under the contract is transferred to the customer at a point in time (shipment) or over time (as we manufacture the product). The Company is first required to evaluate whether its contracts meet the criteria for 'over-time' or 'point-in-time' recognition. The Company has determined that for the majority of its contracts the Company is manufacturing products for which there is no alternative use due to the unique nature of the customer-specific product, IP and other contract restrictions. The Company has an enforceable right to payment including a reasonable profit for performance completed to date with respect to these contracts. As a result, revenue is recognized under these contracts 'over-time' based on the input cost-to-cost method as it better depicts the transfer of control. This input method is based on the ratio of costs incurred to date as compared to the total estimated costs at completion of the performance obligation. For all other contracts that do not meet these criteria, such as manufacturing contracts for which the terms do not provide an enforceable right to payment for performance completed to date, the Company recognizes revenue when it has transferred control of the related manufactured products which generally occurs upon shipment to the customer. Revenue from engineering services is recognized over time as the services are performed. Shipping and Handling Fees The Company classifies costs associated with shipping and handling fees as a component of cost of goods sold. Customer billings related to shipping and handling fees are reported as revenue. Research, Development and Engineering Research, development and engineering expenses include unreimbursed EMS costs as well as design and engineering costs associated with the production of EMS programs. Research, development and engineering costs are expensed as incurred. Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences and benefits attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, as well as tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which temporary differences and carryforwards are expected to be recovered or settled. The effect on deferred tax assets and liabilities for a change in tax rates is recognized in the period that includes the enactment date. Valuation allowances are established when necessary to reduce deferred tax assets to the amount that is more likely than not to be realized. We utilize a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount which is more than 50% likely of being realized upon ultimate settlement. We consider many factors when evaluating and estimating our tax positions and tax benefits, which may require periodic adjustments based on new assessments and changes in estimates and which may not accurately forecast actual outcomes. Our policy is to recognize interest and penalties related to the underpayment of income taxes as a component of income tax provision. To date, we have not incurred charges for interest or penalties in relation to the underpayment of income taxes. The tax years 1997 through the present remain open to examination by the major U.S. taxing jurisdictions to which we are subject. Refer to Note 6 for further discussions. Derivative Instruments and Hedging Activities The Company has entered into foreign currency forward contracts and an interest rate swap which are accounted for as cash flow hedges in accordance with ASC 815, Derivatives and Hedging . The effective portion of the gain or loss on the derivative is reported as a component of accumulated other comprehensive income (AOCI) and is reclassified into earnings in the same period in which the underlying hedged transaction affects earnings. The derivative’s effectiveness represents the change in fair value of the hedge that offsets the change in fair value of the hedged item. The Company uses derivatives to manage the variability of foreign currency fluctuations of expenses in our Mexico facilities. The foreign currency forward contracts and interest rate swaps have terms that are matched to the underlying transactions being hedged. As a result, these transactions fully offset the hedged risk and no ineffectiveness has been recorded. The Company’s foreign currency forward contracts and interest rate swaps potentially expose the Company to credit risk to the extent the counterparties may be unable to meet the terms of the agreement. The Company minimizes such risk by seeking high quality counterparties. The Company’s counterparties to the foreign currency forward contracts and interest rate swaps are major banking institutions. These institutions do not require collateral for the contracts, and the Company believes that the risk of the counterparties failing to meet their contractual obligations is remote. The Company does not enter into derivative instruments for trading or speculative purposes. Earnings Per Common Share Basic earnings per common share is computed by dividing net income by the weighted average number of common shares outstanding during the period. Diluted earnings per common share is computed by dividing net income by the combination of other potentially dilutive weighted average common shares and the weighted average number of common shares outstanding during the period using the treasury stock method. The computation assumes the proceeds from the exercise of stock options were used to repurchase common shares at the average market price during the period. The computation of diluted earnings per common share does not assume conversion, exercise, or contingent issuance of common stock equivalent shares that would have an anti-dilutive effect on earnings per share. Foreign Currency Transactions The functional currency of the Company’s subsidiaries in Mexico and China is the U.S. dollar. Realized foreign currency transaction gains and losses for local currency denominated assets and liabilities are included in cost of goods sold. Fair Value of Financial Instruments The carrying values of cash and cash equivalents, accounts receivable, current liabilities, and non current operating lease liability are reflected on the balance sheets at June 27, 2020 and June 29, 2019, reasonably approximate their fair value. The Company had an outstanding balance on the line of credit of $60.1 million as of June 27, 2020 and $23.4 million as of June 29, 2019, with a carrying value that reasonably approximates the fair value. The Company had an outstanding balance on the term loan of $10.0 million as of June 27, 2020 and $11.3 million as of June 29, 2019, with a carrying value that reasonably approximates the fair value. The equipment term loan is estimated to be $0.9 million as of June 27, 2020 and $1.7 million as of June 29, 2019, with a carrying value that reasonably approximates the fair value. Share-based Compensation The Company’s incentive plan may provide for equity and liability awards to employees in the form of stock options, stock appreciation rights, restricted stock, restricted stock units, stock awards, stock units, performance shares, performance units, and other stock-based or cash-based awards. Compensation cost is recognized on a straight-line basis over the requisite employee service period, which is generally the vesting period, and is included in cost of goods sold, research, development and engineering, and selling, general, and administrative expenses. Share-based compensation is recognized only for those awards that are expected to vest, with forfeitures estimated at the date of grant based on historical experience and future expectations. Newly Adopted and Recent Accounting Pronouncements In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes (Topic 740), which modifies certain provisions of ASC 740, Income Taxes, in an effort to reduce the complexity of accounting for income taxes. ASU 2019-12 is effective for us the first quarter of fiscal year 2022. We are currently evaluating the effects and do not believe this standard will have a material impact on our consolidated financial position, results of operations, or cash flows. In June 2018, the FASB issued ASU 2018-07 "Compensation - Stock Compensation (Topic 718): Improvement to Nonemployee Share-Based Payment Accounting" with the objective of simplifying several aspects of the accounting for nonemployee share-based payment transactions in current GAAP. The Company adopted this guidance during the first quarter of fiscal year 2020 with an immaterial impact on its consolidated financial statements. In August 2017, the FASB issued ASU 2017-12 "Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities" with the objective of improving the financial reporting of hedging relationships and simplifying the application of the hedge accounting guidance in current GAAP. The Company adopted this guidance during the first quarter of fiscal year 2020 with no impact on its consolidated financial statements. In February 2016, the FASB issued Accounting Standards Update ASU 2016-02, Leases which supersedes ASC 840 Leases and creates a new topic, ASC 842 Leases. This update requires lessees to recognize a lease asset and a lease liability for all leases, including operating leases, with a term greater than 12 months on its balance sheet. The update also expands the required quantitative and qualitative disclosures surrounding leases. The Company adopted ASC 842 on June 30, 2019 using the modified retrospective method for leases existing at June 30, 2019. As a result, the Company was not required to adjust its comparative period financial information for effects of the standard or make the new required lease disclosures for periods before our adoption date. Management elected the package of practical expedients which, among other things, allows the Company to carry forward historical lease classification in place prior to June 30, 2019. ASC 842 also provides practical expedients for an entity’s accounting after transition. Management has elected the short-term lease recognition exemption for all leases that qualify, as well as the practical expedient to not separate lease and non-lease components. Both of these expedients were elected for all classes of underlying leased assets. As the Company cannot determine the interest rate implicit in the lease for its leases, the Company uses its estimate of the incremental borrowing rate as of the commencement date in determining the present value of lease payments. The Company’s estimated incremental borrowing rate is the rate of interest it would have to pay on a collateralized basis over a similar term in an amount equal to the lease payments in a similar economic environment. The lease term for all of the Company’s leases includes the noncancellable period of the lease plus any additional periods covered by either an option to extend (or not to terminate) the lease that the Company is reasonably certain to exercise. The adoption of ASC 842 had a material impact to the Company’s consolidated balance sheet, but did not materially impact the consolidated statement of income or consolidated statement of cash flows. The most significant changes to the consolidated balance sheet relate to the recognition of new right-of-use (ROU) assets and lease liabilities for operating leases. As a result of adopting ASC 842 as of June 30, 2019, the Company recognized an ROU asset of $21.4 million, a corresponding lease liability of $20.4 million, a reduction in prepaid rent of $0.4 million, a reduction of favorable lease agreement intangible of $0.7 million, and no adjustment to retained earnings or future P&L impact. In June 2016, the FASB issued ASU 2016-13 “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” and also issued subsequent amendments to the initial guidance: ASU 2018-19, ASU 2019-04 and ASU 2019-05, which replaces the existing incurred loss impairment model with an expected credit loss model and requires a financial asset measured at amortized cost to be presented at the net amount expected to be collected. The guidance is effective for the Company beginning in the first quarter of fiscal year 2024 with early adoption permitted. The Company is currently assessing the impact on its consolidated financial statements, and it intends to adopt the guidance when it becomes effective in the first quarter of fiscal year 2024. The Company adopted Accounting Standards Update 2014-09 (ASU 2014-09), Revenue from Contracts with Customers (Topic 606) (also referred to as Accounting Standard Codification 606 (“ASC 606”) on July 1, 2018 using the modified retrospective approach by applying the guidance to all open contracts at the adoption date and has implemented revised accounting policies, new operational and financial reporting processes, enhanced systems capabilities and relevant internal controls. As part of adopting ASC 606, revenue for certain customer contracts where the Company is manufacturing products for which there is no alternative use and the Company has an enforceable right to payment including a reasonable profit for work-in-progress inventory will be recognized over time instead of upon shipment of products. The cumulative effect of change made to our July 1, 2018 consolidated balance sheet for the adoption of ASC 606 was as follows: Consolidated Balance Sheet Impact of Adopting ASC 606 (Unaudited, in thousands) Balance at June 30, 2018 Adjustments Balance at July 1, 2018 ASSETS Contract assets — 11,906 11,906 Inventories 110,315 (11,210) 99,105 Deferred income tax asset 7,882 (167) 7,715 LIABILITIES AND SHAREHOLDERS’ EQUITY Retained earnings 72,806 529 73,335 The following tables summarize the impacts of ASC 606 adoption on the Company’s consolidated balance sheets and consolidated statements of income (loss): Consolidated Balance Sheet As of June 29, 2019 Impact of Adopting ASC 606 (Unaudited, in thousands) As Reported 606 Adjustment Balance without 606 Adoption ASSETS Contract assets 22,161 (22,161) — Inventories 100,431 19,563 119,994 Deferred income tax asset 7,840 167 8,007 LIABILITIES AND SHAREHOLDERS’ EQUITY Retained earnings 65,353 2,431 62,922 Consolidated Statement of Income (Loss) Impact of Adopting ASC 606 (Unaudited, in thousands) Twelve Months Ended June 29, 2019 As Reported 606 Adjustment Balance without 606 Adoption Net sales $ 464,044 $ 10,254 $ 453,790 Cost of sales $ 429,443 $ 8,353 $ 421,090 Gross profit $ 34,601 $ 1,901 $ 32,700 Net income $ (7,982) $ 1,901 $ (9,883) For the fiscal year ended June 29, 2019, the reported revenue and gross profit was approximately $464.0 million, and $34.6 million; respectively. This reflects the adoption of ASC 606 as revenue and gross profit would have been $10.3 million and $1.9 million less without ASC 606 adoption; respectively. This is primarily due to the change from 'point-in-time' to 'over-time' recognition as the standard requires. There was not a material tax impact for the twelve months ended June 29, 2019 from adopting ASC 606. Fiscal Year The Company operates on a 52/53 week fiscal year. Fiscal years end on the Saturday nearest June 30. As such, fiscal years 2020, 2019, and 2018, ended on June 27, 2020, June 29, 2019, and June 30, 2018, respectively. Fiscal year 2020, 2019 and 2018 were all 52 week years. |
INVENTORIES
INVENTORIES | 12 Months Ended |
Jun. 27, 2020 | |
Inventory Disclosure [Abstract] | |
INVENTORIES | INVENTORIES The components of inventories consist of the following (in thousands): June 27, 2020 June 29, 2019 Finished goods $ 15,269 $ 11,969 Work-in-process 17,390 11,705 Raw materials and supplies 82,361 76,757 $ 115,020 $ 100,431 |
PROPERTY, PLANT AND EQUIPMENT
PROPERTY, PLANT AND EQUIPMENT | 12 Months Ended |
Jun. 27, 2020 | |
Property, Plant and Equipment [Abstract] | |
PROPERTY, PLANT AND EQUIPMENT | PROPERTY, PLANT AND EQUIPMENT Property, plant and equipment consists of the following: Life June 27, 2020 June 29, 2019 (in years) (in thousands) Land — $ 4,034 $ 2,940 Buildings and improvements 3 to 30 23,444 23,776 Equipment 1 to 10 72,151 67,348 Furniture and fixtures 3 to 5 4,883 4,248 Total Property, Plant and Equipment 104,512 98,312 Accumulated depreciation (72,748) (68,899) Property, Plant and Equipment, net $ 31,764 $ 29,413 |
LONG-TERM DEBT
LONG-TERM DEBT | 12 Months Ended |
Jun. 27, 2020 | |
Debt Disclosure [Abstract] | |
LONG-TERM DEBT | LONG-TERM DEBT On March 5, 2020, the Company entered into a Seventh amendment to the amended and restated credit agreement extending the limit on our line of credit facility to $65.0 million. Outside of the limit increase of the credit facility, the agreement reflects the same specifications and terms as the sixth amendment to the amended and restated credit agreement entered into by the Company on November 20, 2019; discussed below. As of June 27, 2020, the Company had an outstanding balance under the credit facility of $60.1 million, $0.4 million in outstanding letters of credit and $4.5 million available for future borrowings. As of June 29, 2019, the Company had an outstanding balance under the credit facility of $23.4 million, $0.4 million in outstanding letters of credit and $21.3 million available for future borrowings. The Company's debt was paid in full in conjunction with the closing of a new credit facility subsequent to June 27, 2020. Refer to footnote 17 - Subsequent Events for additional details. On November 20, 2019, the Company entered into a Sixth amendment to the amended and restated credit agreement extending the limit on our line of credit facility to $55.0 million as evidenced by the Second Replacement Revolving Note. The agreement specifies that the proceeds of the revolving line of credit be used primarily for working capital and general corporate purposes. The line of credit is secured by substantially all of the assets of the Company. On September 30, 2018, the Company entered into a Fourth amendment to the amended and restated credit agreement to extend the maturity date to November 1, 2023, at which time all outstanding balances are payable. On September 10, 2019, the Company entered into a Fifth amendment to the amended and restated credit agreement to increase the outstanding balance on the term loan in the amount of $5.0 million and to extend the maturity date to September 30, 2022 on the original term loan in the amount of $35.0 million that was used to acquire all of the outstanding shares of CDR Manufacturing, Inc. (dba Ayrshire Electronics). The term loan requires quarterly payments of $1.67 million commencing December 31, 2019 through September 30, 2021, and quarterly payments of $0.4 million commencing December 31, 2021 through September 30, 2022, with a final payment of the remaining outstanding balance on September 30, 2022. The Company had an outstanding balance of $10.0 million and $11.3 million under the term loan as of June 27, 2020 and June 29, 2019, respectively. On December 28, 2016, the Company entered into an equipment term loan agreement in the amount of $3.9 million in order to further invest in production equipment. The equipment term loan is collateralized by production equipment. Under this loan agreement, equal quarterly payments of approximately $0.2 million commenced on March 31, 2017 and will continue through the maturity of the equipment term loan on June 30, 2021. Amortization of the debt issuance costs is reported as interest expense on the consolidated income statement. As of June 27, 2020, the Company had an outstanding balance of $0.9 million. As of June 29, 2019, the Company had an outstanding balance of $1.7 million. The Fifth amendment to the amended and restated credit agreement noted above to increase the outstanding balance on the term loan in the amount of $5.0 million fixes borrowings under the revolving line of credit, term loan and equipment term loan to bear interest at LIBOR plus 2.0%, as opposed to previous borrowings at either a “Base Rate” or a “Fixed Rate,” as elected by the Company. The base rate is the higher of the Wells Fargo Bank prime rate, daily one month London Interbank Offered Rate (LIBOR) plus 1.5%, or the Federal Funds rate plus 1.5%. The fixed rate is LIBOR plus 1.75%, LIBOR plus 2.0% or LIBOR plus 2.25% depending on the level of the Company’s trailing four quarters Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA). The interest rates on the outstanding debt as of June 27, 2020 range from 2.17% - 2.18% compared to 4.40% - 5.50% as of June 29, 2019. Debt maturities as of June 27, 2020 for the next four years are as follows (in thousands): Fiscal Years Ending Amount 2021 $ 7,537 2022 2,917 2023 417 2024 60,094 Total debt $ 70,965 Unamortized debt issuance costs (30) Long-term debt, net of debt issuance costs $ 70,935 The Company must comply with certain financial covenants, including a cash flow leverage ratio, an asset coverage ratio and a fixed charge coverage ratio. The credit agreement requires the Company to maintain a minimum profit threshold, limits the maximum capital lease expenditures and restricts the Company from declaring or paying dividends in cash or stock without prior bank approval. The Company was in compliance with all financial covenants as of June 27, 2020. |
INCOME TAXES
INCOME TAXES | 12 Months Ended |
Jun. 27, 2020 | |
Income Tax Disclosure [Abstract] | |
INCOME TAXES | INCOME TAXES Income tax benefit consists of the following: Fiscal Year Ended June 27, 2020 June 29, 2019 June 30, 2018 (in thousands) Current income tax benefit: United States $ 365 $ (537) $ (221) Foreign 154 895 1,722 519 358 1,501 Deferred income tax benefit: United States (1,850) (910) (795) Foreign 892 (206) (823) (958) (1,116) (1,618) Total income tax benefit $ (439) $ (758) $ (117) The Company has gross tax credit carryforwards of approximately $8.8 million at June 27, 2020 consisting of federal research and development (R&D) tax credits. Management has reviewed all deferred tax assets for purposes of determining whether or not a valuation allowance may be required. A valuation allowance against deferred tax assets is required if it is more likely than not that some of the deferred tax assets will not be realized. Based upon the Company’s profitability, forecasted income, and evaluation of all other positive and negative evidence, management determined that it is more likely than not that the deferred tax assets will be realized. Subsequent to the end of the fiscal year ending June 27, 2020, the Treasury Department issued final regulations applicable to the Company’s position with respect to the U.S. taxability of foreign earnings under the global intangible low taxed income (also known as “GILTI”) regime and the deductibility of interest expense under IRC Section 163(j). The Company is still evaluating the impact of these regulations, and, at this time, it does not anticipate any material impact to its current or future income tax positions. On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) was enacted in response to the COVID-19 pandemic. The CARES Act, among other things, permits net operating loss (NOL) carryovers and carrybacks to offset 100% of taxable income for taxable years beginning before 2021. In addition, the CARES Act allows NOLs incurred in 2018, 2019, and 2020 to be carried back to each of the five preceding taxable years to generate a refund of previously paid income taxes. The Company does not expect that the NOL carryback provision of the CARES Act will result in a material cash benefit. In addition, the CARES Act contains modifications on the limitation of business interest for tax years beginning in 2019 and 2020. The modifications to Section 163(j) increase the allowable business interest deduction from 30% of adjusted taxable income to 50% of adjusted taxable income. This modification would increase the allowable interest expense deduction of the Company and result in less taxable income for fiscal year 2020, but is not expected to have a material impact on the provision for income taxes. Also, under the CARES Act, AMT credits not previously refunded for the 2018 tax year are refundable in the 2019 taxable year rather than in years 2019-2021, and taxpayers can elect to claim 100% of the AMT credits in the first taxable year beginning in 2018 by applying for a tentative refund claim on or before December 31, 2020. The Company has made this election by applying for a tentative refund claim. The Company is taking advantage of the deferred payment payroll taxes provision, the impacts of which are not expected to be material. The Company is continuing to evaluate the impacts of other aspects of the CARES Act, and at this time the Company does not believe they will have a material impact on our consolidated financial position, results of operations, or cash flows. On December 22, 2017, the Tax Cuts and Jobs Act (“Tax Act”) was signed into law. The Tax Act reduced Federal corporate tax rates effective January 1, 2018, and changed certain other provisions, many of which were not effective until fiscal year 2019. Effective tax rates for fiscal year 2018, were blended rates reflecting the benefit of two quarters of Federal tax rate reductions. These benefits were offset by discrete expenses relating to the revaluation of our U.S. net deferred tax assets, an adjustment relating to foreign exchange, and required adjustments associated with the transition from a global to a territorial tax system (discussed further below). As a result of the U.S. tax system under the Tax Act from a global to a territorial model, a deemed one-time repatriation of all accumulated earnings and profits (AE&P) in Mexico and China occurred on December 31, 2017 (the “Transition Tax”). On December 22, 2017, the staff of the SEC issued Staff Accounting Bulletin No. 118 (“SAB No. 118”). SAB No. 118 provided guidance on accounting for the tax effects of the 2017 Tax Act and allowed registrants to record provisional amounts for a period of up to one year from the date of enactment of the 2017 Tax Act. In fiscal year 2019, we finalized the Transition Tax calculation, resulting in a net Transition Tax amount of $0.8 million, a decrease of $0.4 million for the fiscal year. In addition to the $0.8 million Transition Tax described above, the Company recognized a $1.3 million discrete expense in fiscal year 2018 due to the revaluation of our U.S. net deferred tax assets. Offsetting these amounts, because of the shift to a territorial system of taxation in the U.S., the Company recognized a discrete benefit of approximately $1.3 million related to reversing its previously recognized estimated liability associated with estimated future repatriations from Mexico and China. In future years, because of the Transition Tax on AE&P described above, repatriations of cash will generally be tax-free in the U.S. However, withholding taxes in China may still apply to any such future repatriations. Management has not changed its indefinite investment assertions with regards to the portion of AE&P in China that may be repatriated in the future. Accordingly, management estimates that future repatriations of cash from China may result in approximately $0.8 million of withholding tax. There would be no offsetting foreign tax credits in the U.S. and as such, this potential liability is a direct cost associated with actual repatriations. Withholding taxes will not apply to future repatriations from Mexico or Vietnam. The Company expects to repatriate a portion of its foreign earnings based on increased net sales growth driving additional capital requirements domestically, cash requirements for potential acquisitions and to implement certain tax strategies. The Company expects to repatriate approximately $7.8 million from China, in the future. All other unremitted foreign earnings are expected to remain permanently reinvested for planned fixed assets purchases and improvements in foreign locations. The Company’s effective tax rate differs from the federal tax rate as follows: Fiscal Year Ended June 27, 2020 June 29, 2019 June 30, 2018 (in thousands) Federal income tax provision (benefit) at statutory rates $ 907 $ (1,836) $ (397) State income taxes, net of federal tax effect 90 (158) (4) Foreign tax rate differences 336 251 103 Tax rate change — — 1,634 Provisional transition tax on accumulated foreign earnings — (384) 1,190 Effect of income tax credits (310) (861) (687) Previously unrecognized tax benefits (1,345) — — Effect of repatriation of foreign earnings, net — (42) (1,484) Goodwill write-off — 1,726 — Global Intangible Low-Taxed Income (GILTI) tax — 150 — Provision to return reconciliation (241) 630 (401) Other 124 (234) (71) Income tax benefit $ (439) $ (758) $ (117) The domestic and foreign components of income (loss) before income taxes were: Fiscal Year Ended June 27, 2020 June 29, 2019 June 30, 2018 (in thousands) Domestic $ 1,142 $ (12,220) $ (4,593) Foreign 3,177 3,480 3,151 Income (loss) before income taxes $ 4,319 $ (8,740) $ (1,442) Deferred income tax assets and liabilities consist of the following at: June 27, 2020 June 29, 2019 (in thousands) Deferred tax assets: Net operating loss $ 184 $ 33 Tax credit carryforwards, net 5,961 4,986 Inventory 1,426 1,087 Identifiable intangibles 493 407 Interest expense carryforward — 474 Accruals 2,847 3,549 Research and development expenses — 232 Mart-to-market adjustments 415 — ASC 606 deferred costs 1,943 2,484 Lease liabilities 3,201 — Other 212 30 Deferred income tax assets $ 16,682 $ 13,282 Deferred tax liabilities: Accrued withholding tax - unremitted earnings (820) (820) Fixed assets (566) (443) Right-of-use assets (3,290) — Mart-to-market adjustments — (730) ASC 606 accelerated revenue (1,344) (3,274) Other (718) (175) Deferred income tax liabilities $ (6,738) $ (5,442) Net deferred income tax assets $ 9,944 $ 7,840 Balance sheet caption reported in: Long-term deferred income tax asset $ 10,178 $ 7,840 Long-term deferred income tax liability (234) — Net deferred income tax asset $ 9,944 $ 7,840 Certain reclassifications have been made in the 2019 information in the above table to conform with 2020 presentation. Uncertain Tax Positions: The Company has R&D tax credits that approximate $8.8 million that have 20-year carryforwards before expiring. The Company’s R&D tax credits expire in various fiscal years from 2026 to 2040. The Company also has alternative minimum tax credits, which do not expire, approximating $347,000, which are now classified as a receivable due to the repeal of the alternative minimum tax. As of June 27, 2020, the Company had unrecognized tax benefits of $2.9 million related to its gross R&D tax credits. The unrecognized tax benefits relate to certain R&D tax credits generated from 2002 to 2020. A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows: Fiscal Year Ended June 27, 2020 June 29, 2019 June 30, 2018 (in thousands) Beginning Balance $ 4,099 $ 4,011 $ 3,947 Additions based on tax positions related to the current year 109 88 64 Lapse of statute of limitations (1,345) — — Ending Balance $ 2,863 $ 4,099 $ 4,011 The increase from the prior year is due to additional R&D credits that were recorded in 2020 as discussed above. Management does not anticipate any material changes to this amount during the next 12 months. The Company recognizes interest accrued related to unrecognized tax benefits and penalties in its income tax provision. The Company has not recognized any interest or penalties in the fiscal years presented in these financial statements. The Company is subject to income tax in the U.S. federal jurisdiction, various state jurisdictions, Mexico, China and Vietnam. Certain years remain subject to examination but there are currently no ongoing exams in any taxing jurisdictions. |
EARNINGS PER SHARE
EARNINGS PER SHARE | 12 Months Ended |
Jun. 27, 2020 | |
Earnings Per Share [Abstract] | |
EARNINGS PER SHARE | EARNINGS PER SHARE Basic earnings per share (EPS) is calculated by dividing net income (the numerator) by the weighted-average number of common shares outstanding (the denominator) during the period. Diluted EPS is computed by including both the weighted-average number of shares outstanding and any dilutive common share equivalents in the denominator. The following table presents a reconciliation of the denominator and the number of antidilutive common share awards that were not included in the diluted earnings per share calculation. These antidilutive securities occur when equity awards outstanding have an option price greater than the average market price for the period: Fiscal Year Ended June 27, 2020 June 29, 2019 June 30, 2018 Net income (loss) $ 4,758 $ (7,982) $ (1,325) Weighted average shares outstanding– basic 10,760 10,760 10,760 Effect of dilutive common stock awards 57 — — Weighted average shares outstanding – diluted 10,816 10,760 10,760 Net income (loss) per share – basic $ 0.44 $ (0.74) $ (0.12) Net income (loss) per share – diluted $ 0.44 $ (0.74) $ (0.12) Antidilutive SARs not included in diluted earnings per share 720 985 827 |
STOCK OPTION AND BENEFIT PLANS
STOCK OPTION AND BENEFIT PLANS | 12 Months Ended |
Jun. 27, 2020 | |
Share-based Payment Arrangement [Abstract] | |
STOCK OPTION AND BENEFIT PLANS | STOCK OPTION AND BENEFIT PLANS The Company’s incentive plan provides for equity and liability awards to employees and non-employee directors in the form of stock options, stock appreciation rights (SARs), restricted stock, restricted stock units, stock awards, stock units, performance shares, performance units, and other stock-based or cash-based awards. Compensation cost is recognized on a straight-line basis over the requisite employee service period, which is generally the vesting period, and is recorded as employee compensation expense in cost of goods sold, research, development and engineering, and selling, general and administrative expenses. Share-based compensation is recognized only for those awards that are expected to vest, with forfeitures estimated at the date of grant based on historical experience and future expectations. In addition to service conditions, these SARs contain a performance condition. The additional performance condition is based upon the achievement of Return on Invested Capital (ROIC) goals relative to a peer group. All awards with performance conditions are measured over the vesting period and are charged to compensation expense over the requisite service period based on the number of shares expected to vest. The SARs cliff vest after a three-year period from date of grant and expire five years from date of grant. On July 26, 2019, the Company granted 175,000 SARs under the 2010 Incentive Plan to certain key employees and outside directors at a strike price of $4.93 and a grant date fair value of $1.23. As of June 27, 2020, 150,000 remain outstanding. The grant date fair value for the awards granted during fiscal year 2020, were estimated using the Black Scholes option valuation method with the following weighted average assumptions as of July 26, 2019: Fiscal Year 2020 July 26, 2019 Expected dividend yield —% Risk – free interest rate 1.54% Expected volatility 28.50% Expected life 4.00 On July 27, 2018, the Company granted 161,250 SARs under the 2010 Incentive Plan to certain key employees and outside directors at a strike price of $8.17 and a grant date fair value of $2.27. As of June 27, 2020, 121,250 remain outstanding. The grant date fair value for the awards granted during fiscal year 2019, were estimated using the Black Scholes option valuation method with the following weighted average assumptions as of July 27, 2018: Fiscal Year 2019 July 27, 2018 Expected dividend yield —% Risk – free interest rate 2.80% Expected volatility 29.75% Expected life 4.00 On July 28, 2017, the Company granted 272,500 SARs under the 2010 Incentive Plan to certain key employees and outside directors at a strike price of $7.26 and a grant date fair value of $1.89. As of June 27, 2020, 197,500 remain outstanding. The grant date fair value for the awards granted during fiscal year 2018, were estimated using the Black Scholes option valuation method with the following weighted average assumptions as of July 28, 2017: Fiscal Year 2018 July 28, 2017 Expected dividend yield —% Risk – free interest rate 1.70% Expected volatility 29.76% Expected life 4.00 Subsequent to June 27, 2020, the Company granted 155,000 SARs with a strike price of $6.94 and a grant date fair value of $2.32. Share-based compensation expense is recognized only for those awards that are expected to vest, with forfeitures estimated at the date of grant based on the Company’s historical experience and future expectations. This forfeiture rate will be revised, if necessary, in subsequent periods if actual forfeitures differ from the amount estimated. Share-based compensation expense for fiscal years ended June 27, 2020, June 29, 2019 and June 30, 2018 was $0.3 million, $0.4 million and $0.4 million, respectively. The Black-Scholes option valuation model is used by the Company for estimating the fair value of SARs. Option valuation models require the input of highly subjective assumptions, particularly for the expected term and expected stock price volatility. Changes in these assumptions can materially affect the fair value estimates. There were no SARs exercised during fiscal year 2020, 2019 or 2018. As of June 27, 2020, total unrecognized compensation expense related to nonvested share-based compensation arrangements was approximately $0.2 million. This expense is expected to be recognized over a weighted-average period of 1.58 years. The following table summarizes the Company’s Options and SARs activity for all plans from July 2, 2016 through June 27, 2020: SARs SARs Aggregate Weighted Weighted Balances, July 1, 2017 394,335 1,084,999 $ — $ 9.09 2.3 Shares authorized — — SARs granted (272,500) 272,500 7.26 SARs forfeited 282,500 (282,500) 7.84 SARs exercised — — — — Balances June 30, 2018 404,335 1,074,999 $ 79 $ 8.90 2.3 Shares authorized — — SARs granted (161,250) 161,250 8.17 SARs forfeited 250,833 (250,833) 10.59 SARs exercised — — — — Balances, June 29, 2019 493,918 985,416 $ — $ 8.35 1.7 Shares authorized — — SARs granted (175,000) 175,000 4.93 SARs forfeited 290,833 (290,833) 7.71 SARs exercised — — — — Balances, June 27, 2020 609,751 869,583 $ — $ 7.87 1.9 Exercisable at June 27, 2020 400,833 $ — $ 9.18 0.6 Additional information regarding SARs outstanding and exercisable as of June 27, 2020, is as follows: Range of Number Outstanding Weighted Avg. Weighted Avg. Number Weighted $4.40 – $7.90 347,500 2.1 $ 6.25 — $ — 7.91 – 9.91 328,750 0.6 8.17 207,500 8.17 9.92 – 11.34 193,333 0.1 10.26 193,333 10.26 $4.40 to $11.34 869,583 1.9 $ 7.87 400,833 $ 9.18 The Company has defined contribution plans available to U.S. employees who have attained age 21. Company contributions to the plans were approximately $0.8 million, $0.9 million, and $0.8 million during fiscal years 2020, 2019 and 2018, respectively. |
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES | 12 Months Ended |
Jun. 27, 2020 | |
Commitments and Contingencies Disclosure [Abstract] | |
COMMITMENTS AND CONTINGENCIES | COMMITMENTS AND CONTINGENCIES Leases : As of June 27, 2020, June 29, 2019 and June 30, 2018, the Company did not have any property and equipment financed under capital leases. Please refer to Note 16 for information regarding operating lease commitments. Rental expense under operating leases was approximately $4.2 million, $5.0 million, and $7.1 million during fiscal years 2020, 2019 and 2018, respectively. Warranty Costs : The Company provides warranties on certain product sales, and allowances for estimated warranty costs are recorded during the period of sale. The determination of such allowances requires the Company to make estimates of product return rates and expected costs to repair or to replace the products under warranty. The Company establishes warranty reserves based on historical warranty costs for each product line combined with liability estimates based on the prior twelve months’ sales activities. As of June 27, 2020 and June 29, 2019, the reserve for warranty costs was approximately $15,000 and $22,000, respectively. If actual return rates and/or repair and replacement costs differ significantly from estimates, adjustments to recognize additional cost of sales may be required in future periods. Warranty expense for fiscal years 2020, 2019 and 2018 was related to workmanship claims on certain EMS products. Litigation : The Company is party to certain lawsuits or claims in the ordinary course of business. The Company does not believe that these proceedings, individually or in the aggregate, will have a material adverse effect on the financial position, results of operations or cash flow of the Company. Indemnification Rights : Under the Company’s bylaws, the Company’s directors and officers have certain rights to indemnification by the Company against certain liabilities that may arise by reason of their status or service as directors or officers. The Company maintains director and officer insurance, which may cover certain liabilities arising from its obligation to indemnify its directors and officers and former directors in certain circumstances. |
DERIVATIVE FINANCIAL INSTRUMENT
DERIVATIVE FINANCIAL INSTRUMENTS | 12 Months Ended |
Jun. 27, 2020 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
DERIVATIVE FINANCIAL INSTRUMENTS | DERIVATIVE FINANCIAL INSTRUMENTS As of June 27, 2020, the Company had outstanding foreign currency forward contracts and swaps with a total notional amount of $36.7 million. The maturity dates for these contracts and swaps extend through December 2021. As of June 27, 2020, the net amount of unrealized loss expected to be reclassified into earnings within the next 12 months is approximately $1.8 million. During the fiscal year ended June 27, 2020, the Company entered into $23.8 million of foreign currency forward contracts and settled $26.7 million of such contracts. During the fiscal year ended June 29, 2019, the Company entered into $19.2 million of foreign currency forward contracts and settled $25.9 million of such contracts. During the fiscal year ended June 30, 2018, the Company entered into $13.7 million of foreign currency forward contracts and settled $28.1 million of such contracts. As of June 27, 2020, the aggregate notional amount of the Company’s outstanding foreign currency contracts and swaps along with their unrealized gains (losses) are expected to mature as summarized below (in thousands): Quarter Ending Notional Contracts and Swaps in MXN Notional Contracts and Swaps in USD Estimated Fair Value September 26, 2020 $ 141,173 $ 6,729 $ (623) December 26, 2020 $ 132,773 $ 6,241 $ (561) April 3, 2021 $ 148,253 $ 6,682 $ (425) July 3, 2021 $ 144,725 $ 6,446 $ (367) October 2, 2021 $ 146,373 $ 5,502 $ 564 January 1, 2022 $ 137,973 $ 5,129 $ 532 On November 6, 2019, the Company entered into an interest rate swap contract with an effective date of November 6, 2019 and a termination date of September 30, 2022, with a notional amount of $15.0 million related to the borrowings outstanding under the term loan. This interest rate swap pays the Company variable interest at the one month LIBOR rate, and the Company pays the counter party a fixed interest rate. The fixed interest rate for the contract is 1.70% that replaces the one month LIBOR rate component of our contractual interest to be paid to WFB as part of our term loan. Based on the terms of the interest rate swap contract and the underlying borrowings outstanding under the term loan, the interest rate contract was determined to be effective, and thus qualified as a cash flow hedge. As of June 27, 2020, the remaining notional balance of this swap was $11.7 million. On November 6, 2019, the Company entered into an interest rate swap contract with an effective date of November 6, 2019 and a termination date of November 1, 2023, with a notional amount of $15.0 million related to the borrowings outstanding under the line of credit. This interest rate swap pays the Company variable interest at the one month LIBOR rate, and the Company pays the counter party a fixed interest rate. The fixed interest rate for the contract is 1.67% that replaces the one month LIBOR rate component of our contractual interest to be paid to WFB as part of our line of credit. Based on the terms of the interest rate swap contract and the underlying borrowings outstanding under the line of credit, the interest rate contract was determined to be effective, and thus qualified as a cash flow hedge. In conjunction with the new credit facility, the interest rate swap contracts have been terminated. Please refer to footnote 17 Subsequent Event for more information. The following table summarizes the fair value of derivative instruments in the Consolidated Balance Sheets as of June 27, 2020 and June 29, 2019 (in thousands): June 27, 2020 June 29, 2019 Derivatives Designated as Hedging Instruments Balance Sheet Location Fair Value Fair Value Foreign currency forward contracts & swaps Other current assets $ — $ 2,912 Foreign currency forward contracts & swaps Other long-term assets $ 1,097 $ 320 Foreign currency forward contracts & swaps Other current liabilities $ (1,960) $ — Foreign currency forward contracts & swaps Other long-term liabilities $ (17) $ — Interest rate swaps Other current assets $ — $ 2 Interest rate swaps Other current liabilities $ (347) $ — Interest rate swaps Other long-term liabilities $ (610) $ — The following table summarizes the gain (loss) on derivative instruments, net of tax, on the Consolidated Statements of Income for the fiscal year 2020 (in thousands): Derivatives Designated as Hedging Instruments Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) AOCI Balance Effective Effective Portion AOCI Balance Forward contracts & swaps Cost of sales $ 2,424 $ (865) $ (2,318) $ (759) Interest rate swap Interest expense 2 (782) 39 (741) Total $ 2,426 $ (1,647) $ (2,279) $ (1,500) The following table summarizes the gain (loss) on derivative instruments, net of tax, on the Consolidated Statements of Income for the fiscal year 2019 (in thousands): Derivatives Designated as Hedging Instruments Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) AOCI Balance Effective Effective Portion AOCI Balance Forward contracts & swaps Cost of sales $ (988) $ 3,332 $ 80 $ 2,424 Interest rate swap Interest expense 19 2 (19) 2 Total $ (969) $ 3,334 $ 61 $ 2,426 The following table summarizes the gain (loss) on derivative instruments, net of tax, on the Consolidated Statements of Income for the fiscal year 2018 (in thousands): Derivatives Designated as Hedging Instruments Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) AOCI Balance Effective Tax Rate Effect Reclassification Effective Portion AOCI Balance Forward contracts & swaps Cost of sales $ (2,707) $ (1,942) $ (583) $ 4,244 $ (988) Interest rate swap Interest expense (68) 20 (3) 70 19 Total $ (2,775) $ (1,922) $ (586) $ 4,314 $ (969) As of June 27, 2020, the Company does not have any foreign exchange contracts with credit-risk-related contingent features. The Company is subject to the risk of fluctuating interest rates from our line of credit and foreign currency risk resulting from our China operations. The Company does not currently manage these risk exposures by using derivative instruments. |
FAIR VALUE MEASUREMENTS
FAIR VALUE MEASUREMENTS | 12 Months Ended |
Jun. 27, 2020 | |
Fair Value Disclosures [Abstract] | |
FAIR VALUE MEASUREMENTS | FAIR VALUE MEASUREMENTS The Company has adopted ASC 820, Fair Value Measurements, which defines fair value, establishes a framework for assets and liabilities being measured and reported at fair value and expands disclosures about fair value measurements. There are three levels of fair value hierarchy inputs used to value assets and liabilities which include: Level 1 – inputs are quoted market prices for identical assets or liabilities; Level 2 – inputs other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly; and Level 3 – inputs are unobservable inputs for the asset or liability. There have been no changes in the fair value methodologies used at June 27, 2020 and June 29, 2019. The following table summarizes the fair value of assets (liabilities) of the Company’s derivatives that are required to be measured on a recurring basis as of June 27, 2020 and June 29, 2019 (in thousands): June 27, 2020 Level 1 Level 2 Level 3 Total Financial Assets: Foreign currency forward contracts & swaps $ — $ 1,097 $ — $ 1,097 Financial Liabilities: Interest rate swaps $ — $ (957) $ — $ (957) Foreign currency forward contracts & swaps $ — $ (1,977) $ — $ (1,977) June 29, 2019 Level 1 Level 2 Level 3 Total Financial Assets: Interest rate swaps $ — $ 2 $ — $ 2 Foreign currency forward contracts & swaps — 3,232 — $ 3,232 The Company currently has forward contracts to hedge known future cash outflows for expenses denominated in the Mexican peso and an interest rate swap to mitigate risk associated with certain borrowings under the Company’s debt arrangement. These contracts are measured on a recurring basis based on the foreign currency spot rates and forward rates quoted by banks or foreign currency dealers. These contracts are marked to market using level 2 input criteria every quarter with the unrealized gain or loss, net of tax, reported as a component of shareholders’ equity in accumulated other comprehensive income (loss), as they qualify for hedge accounting. The carrying values of cash and cash equivalents, accounts receivable, current liabilities, and non current lease liability are reflected on the balance sheets at June 27, 2020 and June 29, 2019, reasonably approximate their fair value. The Company’s long-term debt, which is measured at amortized cost, primarily consists of a revolving line of credit, a term loan and an equipment term loan. These borrowings bear interest at either a “Base Rate” or a “Fixed Rate,” as elected by the Company. Each of these rates is a variable floating rate dependent upon current market conditions and the Company’s current credit risk as discussed in footnote 4. As a result of the determinable market rate for our revolving line of credit, term loan and equipment term, they are classified within Level 2 of the fair value hierarchy. Further, the carrying value of each of these instruments reasonably approximates their fair value as of June 27, 2020 and June 29, 2019. Other assets and liabilities held by the Company may be required to be measured at fair value on a non recurring basis. As of June 29, 2019, the customer relationship intangibles were written down to their fair value of $0. This measurement was the result of certain triggering events that occurred during the third quarter of fiscal year 2019. Refer to Note 14 for further discussion of the impairment. |
ENTERPRISE-WIDE DISCLOSURES
ENTERPRISE-WIDE DISCLOSURES | 12 Months Ended |
Jun. 27, 2020 | |
Segment Reporting [Abstract] | |
ENTERPRISE-WIDE DISCLOSURES | ENTERPRISE-WIDE DISCLOSURES Operating segments are defined in ASC Topic 280, Segment Reporting as components of an enterprise for which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision making group, in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision maker is its Chief Executive Officer. As of June 27, 2020, the Company operates and internally manages a single operating segment, Electronics Manufacturing Services as this is the only discrete financial information that is regularly reviewed by the chief operating decision maker. This segment provides integrated electronic and mechanical engineering, assembly, sourcing and procurement, logistics, and new product testing for our customers. Products and Services Of the revenues for the years ended June 27, 2020, June 29, 2019, and June 30, 2018, EMS sales and services were $449.5 million, $463.9 million and $445.8 million, respectively. Keyboard sales for the years ended June 27, 2020, June 29, 2019, and June 30, 2018 were $4,000, $0.1 million and $0.5 million, respectively. Geographic Areas Net sales and long-lived assets (property, plant, and equipment) by geographic area for the years ended and as of June 27, 2020, June 29, 2019 and June 30, 2018 are summarized in the following table. Net sales set forth below are based on the shipping destination. Long-lived assets information is based on the physical location of the asset. Fiscal Year Ended (in thousands) 2020 2019 2018 Geographic net sales: Domestic (U.S.) $ 338,766 $ 357,341 $ 329,230 Foreign 110,714 106,703 117,092 Total $ 449,480 $ 464,044 $ 446,322 Long-lived assets: United States $ 9,213 $ 9,658 $ 7,454 Mexico 19,325 17,781 19,395 Vietnam 2,644 1,220 — China 582 754 699 Total $ 31,764 $ 29,413 $ 27,548 Percentage of net sales made to customers located in the following countries: Fiscal Year Ended 2020 2019 2018 United States 75% 77% 74% China 19 19 24 Other foreign countries (a) 5 3 2 Canada 1 1 — Total 100% 100% 100% (a) No other individual foreign country accounted for 10% or more of the foreign sales in fiscal years 2020, 2019 or 2018. Significant Customers The percentage of net sales to and trade accounts receivables from significant customers were as follows: Percentage of Net Percentage of 2020 2019 2018 2020 2019 Customer A 18% 17% 19% 14% 11% Customer B * * * 12 % * * Current customer amount represents less than 10%. |
QUARTERLY FINANCIAL DATA
QUARTERLY FINANCIAL DATA | 12 Months Ended |
Jun. 27, 2020 | |
Quarterly Financial Information Disclosure [Abstract] | |
QUARTERLY FINANCIAL DATA | QUARTERLY FINANCIAL DATA (Unaudited) Fiscal Year Ended June 27, 2020 First Second Third Fourth (in thousands, except per share amounts) Net sales $ 105,285 $ 116,722 $ 111,455 $ 116,018 Gross profit 9,273 8,122 9,248 8,606 Income before income taxes 1,829 974 1,010 506 Net income 1,552 824 910 1,472 Net income per share - basic $ 0.14 $ 0.08 $ 0.08 $ 0.14 Net income per share - diluted $ 0.14 $ 0.08 $ 0.08 $ 0.14 Weighted average shares outstanding Basic 10,760 10,760 10,760 10,760 Diluted 10,805 10,877 10,885 10,832 Fiscal Year Ended June 29, 2019 First Second Third Fourth (in thousands, except per share amounts) Net sales $ 127,472 $ 123,037 $ 107,954 $ 105,581 Gross profit 9,533 9,880 6,807 8,381 Income (loss) before income taxes 1,868 1,916 (13,256) 732 Net income (loss) 1,593 1,589 (11,981) 817 Net income (loss) per share - basic $ 0.15 $ 0.15 $ (1.11) $ 0.08 Net income (loss) per share - diluted $ 0.15 $ 0.15 $ (1.11) $ 0.08 Weighted average shares outstanding Basic 10,760 10,760 10,760 10,760 Diluted 10,979 10,881 10,760 10,760 |
GOODWILL AND OTHER INTANGIBLE A
GOODWILL AND OTHER INTANGIBLE ASSETS | 12 Months Ended |
Jun. 27, 2020 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
GOODWILL AND INTANGIBLE ASSETS | GOODWILL AND OTHER INTANGIBLE ASSETS The Company recorded goodwill in connection with the Ayrshire and Sabre acquisitions resulting primarily from the synergies that resulted from the Company's acquisitions and the assembled workforce. The goodwill is not amortized for financial accounting purposes. In accordance with accounting guidance on goodwill and other intangible assets, the Company evaluates goodwill for impairment at the reporting unit level annually, and whenever circumstances occur indicating that goodwill might be impaired. Upon adoption of ASU 2017-04, the Company now recognizes an impairment charge (not to exceed the total amount of goodwill allocated to the reporting unit) for the amount by which the carrying amount of a reporting unit exceeds the reporting unit’s fair value. During the third quarter of fiscal year 2019, a goodwill impairment of $10.0 million was recognized. During the third quarter for fiscal year 2019, the Company assessed other finite-lived intangible assets including the Company’s customer relationships and favorable lease agreements due to an indicator of possible impairment being present. As a result of the analysis performed, the Company determined that the carrying value of the customer relationships intangible asset was not recoverable and recorded an impairment for the entire carrying amount during the third quarter of fiscal year 2019. This resulted in an impairment charge related to other intangible assets of $2.5 million recognized in the third quarter of fiscal year 2019. The Company’s analysis did not indicate that any of its other long-lived assets were impaired. During the first quarter of fiscal year 2020, the Company adopted the Accounting Standards Update 2016-02, Leases which supersedes ASC 840 Leases and creates a new topic, ASC 842 Leases. Under ASC 842, any assets or liabilities recognized in accordance with ASC 805 that are related to favorable or unfavorable terms of an operating lease for which an entity is a lessee, the entity should derecognize the asset or liability and commensurately adjust the ROU asset. Refer to footnote 16 for additional disclosure. As such, the Company derecognized the intangible asset and added the offsetting amount to the ROU asset. Resulting in a reduction of favorable lease agreement intangible of $0.7 million, and no adjustment to retained earnings or future P&L impact. The components of acquired intangible assets are as follows (in thousands): June 27, 2020 Amortization Period Gross Carrying Accumulated Derecognition Favorable Lease per ASC 842 Net Carrying Other intangible assets: Favorable Lease Agreements 4 - 7 2,941 (2,284) (657) — Total $ 2,941 $ (2,284) $ (657) $ — June 29, 2019 Amortization Period Gross Carrying Accumulated Impairment Net Carrying Other intangible assets: Non-Compete Agreements 3 - 5 $ 568 $ (568) $ — $ — Customer Relationships 10 4,803 (2,311) (2,492) — Favorable Lease Agreements 4 - 7 2,941 (2,284) — 657 Total $ 8,312 $ (5,163) $ (2,492) $ 657 |
LEASES
LEASES | 12 Months Ended |
Jun. 27, 2020 | |
Leases [Abstract] | |
Lessee, Operating Leases | LEASES The Company has several commitments under operating leases for warehouses, manufacturing facilities, office buildings, and equipment with initial terms that expire at various dates during the next 1 year to 11 years. The Company has some operating leases that include an extension clause. Management has considered the likelihood of exercising each extension option included and estimated the duration of the extension option, for those leases management determined to be reasonably certain, in calculating the lease term for measurement of the right of use asset and liability. For operating leases, management assumed a discount rate of 4% - 5.9%. The weighted average discount rate is disclosed in the tables below. The components of lease cost as of June 27, 2020 were (in thousands): Year Ended Lease cost Classification June 27, 2020 Operating lease cost Cost of sales $ 4,511 Operating lease cost Selling, general and administrative expenses 1,266 Total lease cost $ 5,777 Amounts reported in the Consolidated Balance Sheet as of June 27, 2020 were (in thousands, except weighted average lease term and discount rate): June 27, 2020 Operating Leases: Operating lease right of use assets $ 17,568 Operating lease liabilities (1) 17,173 Weighted-average remaining lease term (in years) Operating leases 6.46 Weighted-average discount rate Operating leases 4.07 % (1) The current portion of the total operating lease liabilities of $4.5 million is classified under Other Current Liabilities, resulting in $12.6 million classified under Operating Lease Liabilities in the Long-term Liabilities section of the consolidated balance sheet. Other information related to leases was as follows (in thousands): June 27, 2020 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases 4,237 The Company entered into one new lease during the fiscal year, resulting in a non-cash impact of $0.4 million. Future lease payments under non-cancellable leases as of June 27, 2020 are as follows (in thousands): Fiscal Years Ending Operating Leases 2021 $ 4,250 2022 3,373 2023 2,598 2024 2,004 2025 1,894 Thereafter 5,674 Total undiscounted lease payments 19,793 Less: present value discount 2,620 Total lease liabilities $ 17,173 As previously disclosed in our Annual Report on Form 10-K for the fiscal year ended June 29, 2019 and under the previous lease accounting standard ASC 840, the aggregate future minimum payments under non-cancellable operating leases, as of June 29, 2019, are as follows (in thousands): Fiscal Years Ending Operating Leases 2020 $ 4,777 2021 3,563 2022 2,641 2023 1,866 2024 1,271 Thereafter 4,121 Total minimum lease payments $ 18,239 |
SUBSEQUENT EVENT
SUBSEQUENT EVENT | 12 Months Ended |
Jun. 27, 2020 | |
Subsequent Events [Abstract] | |
Subsequent Events | On August 14, 2020, the Company entered into a loan and security agreement (the “Loan Agreement”) with Bank of America. The Loan Agreement replaces the Company’s prior amended and restated credit agreement, as amended, with Wells Fargo Bank, N.A. The Loan Agreement provides for a five-year asset-based senior secured revolving credit facility of up to $93 million, maturing on August 14, 2025. In addition, during the term of the Loan Agreement, the Company may increase the aggregate amount of the Credit Facility by up to an additional $25 million, subject to customary conditions, including obtaining a commitment from the Bank (or another lender, if applicable) to such increase. The Credit Facility has been used to pay-off the Prior Credit Facility and costs related to the Loan Agreement, and may be used to pay-off certain other existing debt, to issue letters of credit, and for other business purposes, including working capital needs. Based on the Company’s borrowing base and reserve requirements and after paying off the Prior Credit Facility and related fees and expenses relating to the Credit Facility, immediately following the closing of the Loan Agreement, there was approximately $16 million available under the Credit Facility. |
SCHEDULE II
SCHEDULE II | 12 Months Ended |
Jun. 27, 2020 | |
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] | |
SCHEDULE II | KEY TRONIC CORPORATION AND SUBSIDIARIES CONSOLIDATED VALUATION AND QUALIFYING ACCOUNTS FISCAL YEARS ENDED JUNE 27, 2020, JUNE 29, 2019, AND JUNE 30, 2018 Fiscal Year Ended 2020 2019 2018 (in thousands) Allowance for Obsolete Inventory Balance at beginning of year $ 1,792 $ 1,458 $ 1,306 Provisions 136 91 31 Dispositions 40 243 121 Balance at end of year $ 1,968 $ 1,792 $ 1,458 Allowance for Doubtful Accounts Balance at beginning of year $ 58 $ — $ 84 Provisions (Recovery) 551 58 (84) Write-offs — — — Balance at end of year $ 609 $ 58 $ — |
SIGNIFICANT ACCOUNTING POLICI_2
SIGNIFICANT ACCOUNTING POLICIES (Policies) | 12 Months Ended |
Jun. 27, 2020 | |
Accounting Policies [Abstract] | |
Principles of Consolidation | Principles of Consolidation The consolidated financial statements include the Company and its wholly owned subsidiaries in the United States, Mexico, China and Vietnam. Intercompany balances and transactions have been eliminated during consolidation. |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Estimates include the allowance for doubtful receivables, the provision for obsolete and non-saleable inventories, deferred tax assets and liabilities, uncertain tax positions, valuation of goodwill, impairment of long-lived assets, medical self-funded insurance liability, long-term incentive compensation accrual, the provision for warranty costs, the fair value of stock appreciation rights granted under the Company’s share-based compensation plan and purchase price allocation of acquired businesses. Due to uncertainties with respect to the assumptions and estimates, actual results could differ from those estimates. |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers investments with an original maturity of three months or less to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value. The Company may have cash and cash equivalents at financial institutions that are in excess of federally insured limits from time to time. |
Allowance for Doubtful Accounts | Allowance for Doubtful Accounts The Company evaluates the collectability of accounts receivable and records an allowance for doubtful accounts, which reduces the receivables to an amount that management reasonably estimates will be collected. A specific allowance is recorded against receivables considered to be impaired based on the Company’s knowledge of the financial condition of the customer. In determining the amount of the allowance, the Company considers several factors including the aging of the receivables, the current business environment and historical experience. After all attempts to collect a receivable have failed, the receivable is written off against the allowance. |
Inventories | Inventories Inventories are stated at the lower of cost or net realizable value. Inventory valuation is determined using the first-in, first-out (FIFO) method. Customer orders are based upon forecasted quantities of product manufactured for shipment over defined periods. Raw material inventories are purchased to fulfill these customer requirements. Within these arrangements, customer demands for products frequently change, sometimes creating excess and obsolete inventories. The Company regularly reviews raw material inventories by customer for both excess and obsolete quantities. Wherever possible, the Company attempts to recover its full cost of excess and obsolete inventories from customers or, in some cases, through other markets. When it is determined that the Company’s carrying cost of such excess and obsolete inventories cannot be recovered in full, a charge is taken against income for the difference between the carrying cost and the estimated realizable amount. We also reserve for inventory related to specific customers covered by lead-time assurance agreements when those customers are experiencing financial difficulties or reimbursement is not reasonably assured. |
Property, Plant and Equipment | Property, Plant and Equipment Property, plant and equipment are carried at cost and depreciated using straight-line methods over the expected useful lives of the assets. Repairs and maintenance costs are expensed as incurred. |
Impairment of Goodwill | Impairment of Goodwill In accordance with accounting guidance on goodwill and other intangible assets, the Company evaluates goodwill for impairment at the reporting unit level annually, and whenever circumstances occur indicating that goodwill might be impaired. Upon adoption of ASU 2017-04, the Company now recognizes an impairment charge (not to exceed the total amount of goodwill allocated to the reporting unit) for the amount by which the carrying amount of a reporting unit exceeds the reporting unit’s fair value. During the third quarter of fiscal year 2019, a few large programs declined in revenue and two new programs were delayed. This decrease in the Company’s total revenue combined with book value continuing to exceed market capitalization caused a “triggering event” in which to perform a quantitative impairment analysis as of March 30, 2019. To estimate the fair value of the Company’s equity, the Company used both a market approach and an income approach, based on a discounted cash flows analysis. As of March 30, 2019, market related factors increased expected required rates of return, which also increased the Company’s discount rate used to project future cash flows. Further, push outs of the Company’s forecasted future cash flows relating to delays in customer orders adversely impacted the Company’s discounted cash flows model. As a result, a lower estimate in the Company’s fair value using these two valuation methods indicated an impairment charge. During the third quarter of fiscal year 2019, the Company also assessed other finite-lived intangible assets including the Company’s customer relationships and favorable lease agreements due to an indicator of possible impairment being present, as discussed above. As a result of the analysis performed, the Company determined that the carrying value of the customer relationships intangible asset was not recoverable and recorded an impairment for the entire carrying amount during the third quarter of fiscal year 2019. The Company’s analysis did not indicate that any of its other long-lived assets were impaired. Refer to footnote 14 for impairment analysis for goodwill and other intangibles that occurred during fiscal year 2019, as a result of certain triggering events being present. |
Impairment of Long-Lived Assets | Impairment of Long-lived Assets The Company, using its best estimates based on reasonable and supportable assumptions and projections, reviews assets for impairment whenever events or changes in circumstances have indicated that the carrying amount of its assets might not be recoverable. Impaired assets are reported at the lower of cost or fair value. |
Accrued Warranty | Accrued Warranty An accrual is made for expected warranty costs, with the related expense recognized in cost of goods sold. Management reviews the adequacy of this accrual quarterly based on historical analyses and anticipated product returns. |
Self-funded Insurance | Self-funded Insurance The Company self-funds its domestic employee health plans. The Company contracts with a separate administrative service company to supervise and administer the programs and act as its representative. The Company reduces its risk under this self-funded platform by purchasing stop-loss insurance coverage for high dollar individual claims. In addition, if the aggregate annual claims amount to more than 125 percent of expected claims for the plan year this insurance will also pay those claims amounts exceeding that level. The Company estimates its exposure for claims incurred but not paid at the end of each reporting period and uses historical claims data supplied by the Company’s broker to estimate its self-funded insurance liability. This liability is subject to a total limitation that varies based on employee enrollment and factors that are established at each annual contract renewal. Actual claims experience may differ from the Company’s estimates. Costs related to the administration of the plan and related claims are expensed as incurred. |
Revenue Recognition | Revenue Recognition Prior to the adoption of ASU 2014-09, Revenue from Contracts with Customers (Topic 606), sales revenue from manufacturing is recognized upon shipment of the manufactured product per contractual terms. Upon shipment, title transfers and the customer assumes risks and rewards of ownership of the product. The price to the buyer is fixed or determinable and recoverability is reasonably assured. Unless specifically stated in contractual terms, there are no formal customer acceptance requirements or further obligations related to the manufacturing services; if any such requirements exist, then sales revenue is recognized at the time when such requirements are completed and such obligations are fulfilled. Revenue is recorded net of estimated returns of manufactured product based on management’s analysis of historical returns. Subsequent to the adoption of ASU 2014-09, Revenue from Contracts with Customers (Topic 606) during the year ended June 29, 2019, the first step in its process for revenue recognition is to identify the contract with a customer. A contract is defined as an agreement between two or more parties that creates enforceable rights and obligations. A contract can be written, oral, or implied. The Company generally enters into manufacturing service agreements (“MSA”) with its customers that outlines the terms of the business relationship between the customer and the Company. This includes matters such as warranty, indemnification, transfer of title and risk of loss, liability for excess and obsolete inventory, pricing, payment terms, etc. The Company will also bid on a program-by-program basis for customers in which an executed MSA may not be in place. In these instances, as well as when we have an MSA in place, we receive customer purchase orders for specific quantities and timing of products. As a result, the Company considers its contract with a customer to be the combination of the MSA and the purchase order. The transaction price is fixed and set forth in each purchase order. In the Company's normal course of business, there are no variable pricing components, or material amounts refunded to customers in the form of refunds or rebates. The Company assesses whether control of the product or services promised under the contract is transferred to the customer at a point in time (shipment) or over time (as we manufacture the product). The Company is first required to evaluate whether its contracts meet the criteria for 'over-time' or 'point-in-time' recognition. The Company has determined that for the majority of its contracts the Company is manufacturing products for which there is no alternative use due to the unique nature of the customer-specific product, IP and other contract restrictions. The Company has an enforceable right to payment including a reasonable profit for performance completed to date with respect to these contracts. As a result, revenue is recognized under these contracts 'over-time' based on the input cost-to-cost method as it better depicts the transfer of control. This input method is based on the ratio of costs incurred to date as compared to the total estimated costs at completion of the performance obligation. For all other contracts that do not meet these criteria, such as manufacturing contracts for which the terms do not provide an enforceable right to payment for performance completed to date, the Company recognizes revenue when it has transferred control of the related manufactured products which generally occurs upon shipment to the customer. Revenue from engineering services is recognized over time as the services are performed. |
Shipping and Handling Fees | Shipping and Handling Fees The Company classifies costs associated with shipping and handling fees as a component of cost of goods sold. Customer billings related to shipping and handling fees are reported as revenue. |
Research, Development and Engineering | Research, Development and Engineering Research, development and engineering expenses include unreimbursed EMS costs as well as design and engineering costs associated with the production of EMS programs. Research, development and engineering costs are expensed as incurred. |
Income Taxes | Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences and benefits attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, as well as tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which temporary differences and carryforwards are expected to be recovered or settled. The effect on deferred tax assets and liabilities for a change in tax rates is recognized in the period that includes the enactment date. Valuation allowances are established when necessary to reduce deferred tax assets to the amount that is more likely than not to be realized. |
Derivative Instruments and Hedging Activities | Derivative Instruments and Hedging Activities The Company has entered into foreign currency forward contracts and an interest rate swap which are accounted for as cash flow hedges in accordance with ASC 815, Derivatives and Hedging . The effective portion of the gain or loss on the derivative is reported as a component of accumulated other comprehensive income (AOCI) and is reclassified into earnings in the same period in which the underlying hedged transaction affects earnings. The derivative’s effectiveness represents the change in fair value of the hedge that offsets the change in fair value of the hedged item. The Company uses derivatives to manage the variability of foreign currency fluctuations of expenses in our Mexico facilities. The foreign currency forward contracts and interest rate swaps have terms that are matched to the underlying transactions being hedged. As a result, these transactions fully offset the hedged risk and no ineffectiveness has been recorded. The Company’s foreign currency forward contracts and interest rate swaps potentially expose the Company to credit risk to the extent the counterparties may be unable to meet the terms of the agreement. The Company minimizes such risk by seeking high quality counterparties. The Company’s counterparties to the foreign currency forward contracts and interest rate swaps are major banking institutions. These institutions do not require collateral for the contracts, and the Company believes that the risk of the counterparties failing to meet their contractual obligations is remote. The Company does not enter into derivative instruments for trading or speculative purposes. |
Earnings Per Common Share | Earnings Per Common Share Basic earnings per common share is computed by dividing net income by the weighted average number of common shares outstanding during the period. Diluted earnings per common share is computed by dividing net income by the combination of other potentially dilutive weighted average common shares and the weighted average number of common shares outstanding during the period using the treasury stock method. The computation assumes the proceeds from the exercise of stock options were used to repurchase common shares at the average market price during the period. The computation of diluted earnings per common share does not assume conversion, exercise, or contingent issuance of common stock equivalent shares that would have an anti-dilutive effect on earnings per share. |
Foreign Currency Transactions | Foreign Currency Transactions The functional currency of the Company’s subsidiaries in Mexico and China is the U.S. dollar. Realized foreign currency transaction gains and losses for local currency denominated assets and liabilities are included in cost of goods sold. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The carrying values of cash and cash equivalents, accounts receivable, current liabilities, and non current operating lease liability are reflected on the balance sheets at June 27, 2020 and June 29, 2019, reasonably approximate their fair value. The Company had an outstanding balance on the line of credit of $60.1 million as of June 27, 2020 and $23.4 million as of June 29, 2019, with a carrying value that reasonably approximates the fair value. The Company had an outstanding balance on the term loan of $10.0 million as of June 27, 2020 and $11.3 million as of June 29, 2019, with a carrying value that reasonably approximates the fair value. The equipment term loan is estimated to be $0.9 million as of June 27, 2020 and $1.7 million as of June 29, 2019, with a carrying value that reasonably approximates the fair value. |
Share-based Compensation | Share-based CompensationThe Company’s incentive plan may provide for equity and liability awards to employees in the form of stock options, stock appreciation rights, restricted stock, restricted stock units, stock awards, stock units, performance shares, performance units, and other stock-based or cash-based awards. Compensation cost is recognized on a straight-line basis over the requisite employee service period, which is generally the vesting period, and is included in cost of goods sold, research, development and engineering, and selling, general, and administrative expenses. Share-based compensation is recognized only for those awards that are expected to vest, with forfeitures estimated at the date of grant based on historical experience and future expectations. |
Newly Adopted and Recent Accounting Pronouncements | Newly Adopted and Recent Accounting Pronouncements In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes (Topic 740), which modifies certain provisions of ASC 740, Income Taxes, in an effort to reduce the complexity of accounting for income taxes. ASU 2019-12 is effective for us the first quarter of fiscal year 2022. We are currently evaluating the effects and do not believe this standard will have a material impact on our consolidated financial position, results of operations, or cash flows. In June 2018, the FASB issued ASU 2018-07 "Compensation - Stock Compensation (Topic 718): Improvement to Nonemployee Share-Based Payment Accounting" with the objective of simplifying several aspects of the accounting for nonemployee share-based payment transactions in current GAAP. The Company adopted this guidance during the first quarter of fiscal year 2020 with an immaterial impact on its consolidated financial statements. In August 2017, the FASB issued ASU 2017-12 "Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities" with the objective of improving the financial reporting of hedging relationships and simplifying the application of the hedge accounting guidance in current GAAP. The Company adopted this guidance during the first quarter of fiscal year 2020 with no impact on its consolidated financial statements. In February 2016, the FASB issued Accounting Standards Update ASU 2016-02, Leases which supersedes ASC 840 Leases and creates a new topic, ASC 842 Leases. This update requires lessees to recognize a lease asset and a lease liability for all leases, including operating leases, with a term greater than 12 months on its balance sheet. The update also expands the required quantitative and qualitative disclosures surrounding leases. The Company adopted ASC 842 on June 30, 2019 using the modified retrospective method for leases existing at June 30, 2019. As a result, the Company was not required to adjust its comparative period financial information for effects of the standard or make the new required lease disclosures for periods before our adoption date. Management elected the package of practical expedients which, among other things, allows the Company to carry forward historical lease classification in place prior to June 30, 2019. ASC 842 also provides practical expedients for an entity’s accounting after transition. Management has elected the short-term lease recognition exemption for all leases that qualify, as well as the practical expedient to not separate lease and non-lease components. Both of these expedients were elected for all classes of underlying leased assets. As the Company cannot determine the interest rate implicit in the lease for its leases, the Company uses its estimate of the incremental borrowing rate as of the commencement date in determining the present value of lease payments. The Company’s estimated incremental borrowing rate is the rate of interest it would have to pay on a collateralized basis over a similar term in an amount equal to the lease payments in a similar economic environment. The lease term for all of the Company’s leases includes the noncancellable period of the lease plus any additional periods covered by either an option to extend (or not to terminate) the lease that the Company is reasonably certain to exercise. The adoption of ASC 842 had a material impact to the Company’s consolidated balance sheet, but did not materially impact the consolidated statement of income or consolidated statement of cash flows. The most significant changes to the consolidated balance sheet relate to the recognition of new right-of-use (ROU) assets and lease liabilities for operating leases. As a result of adopting ASC 842 as of June 30, 2019, the Company recognized an ROU asset of $21.4 million, a corresponding lease liability of $20.4 million, a reduction in prepaid rent of $0.4 million, a reduction of favorable lease agreement intangible of $0.7 million, and no adjustment to retained earnings or future P&L impact. In June 2016, the FASB issued ASU 2016-13 “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” and also issued subsequent amendments to the initial guidance: ASU 2018-19, ASU 2019-04 and ASU 2019-05, which replaces the existing incurred loss impairment model with an expected credit loss model and requires a financial asset measured at amortized cost to be presented at the net amount expected to be collected. The guidance is effective for the Company beginning in the first quarter of fiscal year 2024 with early adoption permitted. The Company is currently assessing the impact on its consolidated financial statements, and it intends to adopt the guidance when it becomes effective in the first quarter of fiscal year 2024. The Company adopted Accounting Standards Update 2014-09 (ASU 2014-09), Revenue from Contracts with Customers (Topic 606) (also referred to as Accounting Standard Codification 606 (“ASC 606”) on July 1, 2018 using the modified retrospective approach by applying the guidance to all open contracts at the adoption date and has implemented revised accounting policies, new operational and financial reporting processes, enhanced systems capabilities and relevant internal controls. As part of adopting ASC 606, revenue for certain customer contracts where the Company is manufacturing products for which there is no alternative use and the Company has an enforceable right to payment including a reasonable profit for work-in-progress inventory will be recognized over time instead of upon shipment of products. The cumulative effect of change made to our July 1, 2018 consolidated balance sheet for the adoption of ASC 606 was as follows: Consolidated Balance Sheet Impact of Adopting ASC 606 (Unaudited, in thousands) Balance at June 30, 2018 Adjustments Balance at July 1, 2018 ASSETS Contract assets — 11,906 11,906 Inventories 110,315 (11,210) 99,105 Deferred income tax asset 7,882 (167) 7,715 LIABILITIES AND SHAREHOLDERS’ EQUITY Retained earnings 72,806 529 73,335 The following tables summarize the impacts of ASC 606 adoption on the Company’s consolidated balance sheets and consolidated statements of income (loss): Consolidated Balance Sheet As of June 29, 2019 Impact of Adopting ASC 606 (Unaudited, in thousands) As Reported 606 Adjustment Balance without 606 Adoption ASSETS Contract assets 22,161 (22,161) — Inventories 100,431 19,563 119,994 Deferred income tax asset 7,840 167 8,007 LIABILITIES AND SHAREHOLDERS’ EQUITY Retained earnings 65,353 2,431 62,922 Consolidated Statement of Income (Loss) Impact of Adopting ASC 606 (Unaudited, in thousands) Twelve Months Ended June 29, 2019 As Reported 606 Adjustment Balance without 606 Adoption Net sales $ 464,044 $ 10,254 $ 453,790 Cost of sales $ 429,443 $ 8,353 $ 421,090 Gross profit $ 34,601 $ 1,901 $ 32,700 Net income $ (7,982) $ 1,901 $ (9,883) For the fiscal year ended June 29, 2019, the reported revenue and gross profit was approximately $464.0 million, and $34.6 million; respectively. This reflects the adoption of ASC 606 as revenue and gross profit would have been $10.3 million and $1.9 million less without ASC 606 adoption; respectively. This is primarily due to the change from 'point-in-time' to 'over-time' recognition as the standard requires. There was not a material tax impact for the twelve months ended June 29, 2019 from adopting ASC 606. |
Fiscal Year | Fiscal Year The Company operates on a 52/53 week fiscal year. Fiscal years end on the Saturday nearest June 30. As such, fiscal years 2020, 2019, and 2018, ended on June 27, 2020, June 29, 2019, and June 30, 2018, respectively. Fiscal year 2020, 2019 and 2018 were all 52 week years. |
INVENTORIES (Tables)
INVENTORIES (Tables) | 12 Months Ended |
Jun. 27, 2020 | |
Inventory Disclosure [Abstract] | |
Components of Inventories | The components of inventories consist of the following (in thousands): June 27, 2020 June 29, 2019 Finished goods $ 15,269 $ 11,969 Work-in-process 17,390 11,705 Raw materials and supplies 82,361 76,757 $ 115,020 $ 100,431 |
PROPERTY, PLANT AND EQUIPMENT (
PROPERTY, PLANT AND EQUIPMENT (Tables) | 12 Months Ended |
Jun. 27, 2020 | |
Property, Plant and Equipment [Abstract] | |
Property, Plant and Equipment | Property, plant and equipment consists of the following: Life June 27, 2020 June 29, 2019 (in years) (in thousands) Land — $ 4,034 $ 2,940 Buildings and improvements 3 to 30 23,444 23,776 Equipment 1 to 10 72,151 67,348 Furniture and fixtures 3 to 5 4,883 4,248 Total Property, Plant and Equipment 104,512 98,312 Accumulated depreciation (72,748) (68,899) Property, Plant and Equipment, net $ 31,764 $ 29,413 |
LONG-TERM DEBT (Tables)
LONG-TERM DEBT (Tables) | 12 Months Ended |
Jun. 27, 2020 | |
Debt Disclosure [Abstract] | |
Schedule of Maturities of Long-term Debt | Debt maturities as of June 27, 2020 for the next four years are as follows (in thousands): Fiscal Years Ending Amount 2021 $ 7,537 2022 2,917 2023 417 2024 60,094 Total debt $ 70,965 Unamortized debt issuance costs (30) Long-term debt, net of debt issuance costs $ 70,935 |
INCOME TAXES (Tables)
INCOME TAXES (Tables) | 12 Months Ended |
Jun. 27, 2020 | |
Income Tax Disclosure [Abstract] | |
Schedule of Components of Income Tax Expense (Benefit) | Income tax benefit consists of the following: Fiscal Year Ended June 27, 2020 June 29, 2019 June 30, 2018 (in thousands) Current income tax benefit: United States $ 365 $ (537) $ (221) Foreign 154 895 1,722 519 358 1,501 Deferred income tax benefit: United States (1,850) (910) (795) Foreign 892 (206) (823) (958) (1,116) (1,618) Total income tax benefit $ (439) $ (758) $ (117) |
Effective Tax Rate Reconciliation | The Company’s effective tax rate differs from the federal tax rate as follows: Fiscal Year Ended June 27, 2020 June 29, 2019 June 30, 2018 (in thousands) Federal income tax provision (benefit) at statutory rates $ 907 $ (1,836) $ (397) State income taxes, net of federal tax effect 90 (158) (4) Foreign tax rate differences 336 251 103 Tax rate change — — 1,634 Provisional transition tax on accumulated foreign earnings — (384) 1,190 Effect of income tax credits (310) (861) (687) Previously unrecognized tax benefits (1,345) — — Effect of repatriation of foreign earnings, net — (42) (1,484) Goodwill write-off — 1,726 — Global Intangible Low-Taxed Income (GILTI) tax — 150 — Provision to return reconciliation (241) 630 (401) Other 124 (234) (71) Income tax benefit $ (439) $ (758) $ (117) |
Schedule of Income before Income Tax, Domestic and Foreign | The domestic and foreign components of income (loss) before income taxes were: Fiscal Year Ended June 27, 2020 June 29, 2019 June 30, 2018 (in thousands) Domestic $ 1,142 $ (12,220) $ (4,593) Foreign 3,177 3,480 3,151 Income (loss) before income taxes $ 4,319 $ (8,740) $ (1,442) |
Schedule of Deferred Tax Assets and Liabilities | Deferred income tax assets and liabilities consist of the following at: June 27, 2020 June 29, 2019 (in thousands) Deferred tax assets: Net operating loss $ 184 $ 33 Tax credit carryforwards, net 5,961 4,986 Inventory 1,426 1,087 Identifiable intangibles 493 407 Interest expense carryforward — 474 Accruals 2,847 3,549 Research and development expenses — 232 Mart-to-market adjustments 415 — ASC 606 deferred costs 1,943 2,484 Lease liabilities 3,201 — Other 212 30 Deferred income tax assets $ 16,682 $ 13,282 Deferred tax liabilities: Accrued withholding tax - unremitted earnings (820) (820) Fixed assets (566) (443) Right-of-use assets (3,290) — Mart-to-market adjustments — (730) ASC 606 accelerated revenue (1,344) (3,274) Other (718) (175) Deferred income tax liabilities $ (6,738) $ (5,442) Net deferred income tax assets $ 9,944 $ 7,840 Balance sheet caption reported in: Long-term deferred income tax asset $ 10,178 $ 7,840 Long-term deferred income tax liability (234) — Net deferred income tax asset $ 9,944 $ 7,840 |
Schedule of Unrecognized Tax Benefits Roll Forward | A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows: Fiscal Year Ended June 27, 2020 June 29, 2019 June 30, 2018 (in thousands) Beginning Balance $ 4,099 $ 4,011 $ 3,947 Additions based on tax positions related to the current year 109 88 64 Lapse of statute of limitations (1,345) — — Ending Balance $ 2,863 $ 4,099 $ 4,011 |
EARNINGS PER SHARE (Tables)
EARNINGS PER SHARE (Tables) | 12 Months Ended |
Jun. 27, 2020 | |
Earnings Per Share [Abstract] | |
Reconciliation of Denominator and Number of Antidilutive Common Share Awards not Included in Diluted Earnings Per Share Calculation | The following table presents a reconciliation of the denominator and the number of antidilutive common share awards that were not included in the diluted earnings per share calculation. These antidilutive securities occur when equity awards outstanding have an option price greater than the average market price for the period: Fiscal Year Ended June 27, 2020 June 29, 2019 June 30, 2018 Net income (loss) $ 4,758 $ (7,982) $ (1,325) Weighted average shares outstanding– basic 10,760 10,760 10,760 Effect of dilutive common stock awards 57 — — Weighted average shares outstanding – diluted 10,816 10,760 10,760 Net income (loss) per share – basic $ 0.44 $ (0.74) $ (0.12) Net income (loss) per share – diluted $ 0.44 $ (0.74) $ (0.12) Antidilutive SARs not included in diluted earnings per share 720 985 827 |
STOCK OPTION AND BENEFIT PLANS
STOCK OPTION AND BENEFIT PLANS (Tables) | 12 Months Ended |
Jun. 27, 2020 | |
Share-based Payment Arrangement [Abstract] | |
Grant Date Fair Value for Awards Estimated Using Option Valuation Method with Weighted Average Assumptions | On July 26, 2019, the Company granted 175,000 SARs under the 2010 Incentive Plan to certain key employees and outside directors at a strike price of $4.93 and a grant date fair value of $1.23. As of June 27, 2020, 150,000 remain outstanding. The grant date fair value for the awards granted during fiscal year 2020, were estimated using the Black Scholes option valuation method with the following weighted average assumptions as of July 26, 2019: Fiscal Year 2020 July 26, 2019 Expected dividend yield —% Risk – free interest rate 1.54% Expected volatility 28.50% Expected life 4.00 On July 27, 2018, the Company granted 161,250 SARs under the 2010 Incentive Plan to certain key employees and outside directors at a strike price of $8.17 and a grant date fair value of $2.27. As of June 27, 2020, 121,250 remain outstanding. The grant date fair value for the awards granted during fiscal year 2019, were estimated using the Black Scholes option valuation method with the following weighted average assumptions as of July 27, 2018: Fiscal Year 2019 July 27, 2018 Expected dividend yield —% Risk – free interest rate 2.80% Expected volatility 29.75% Expected life 4.00 On July 28, 2017, the Company granted 272,500 SARs under the 2010 Incentive Plan to certain key employees and outside directors at a strike price of $7.26 and a grant date fair value of $1.89. As of June 27, 2020, 197,500 remain outstanding. The grant date fair value for the awards granted during fiscal year 2018, were estimated using the Black Scholes option valuation method with the following weighted average assumptions as of July 28, 2017: Fiscal Year 2018 July 28, 2017 Expected dividend yield —% Risk – free interest rate 1.70% Expected volatility 29.76% Expected life 4.00 |
Summarizes Option/SARs Activity of All Plans | The following table summarizes the Company’s Options and SARs activity for all plans from July 2, 2016 through June 27, 2020: SARs SARs Aggregate Weighted Weighted Balances, July 1, 2017 394,335 1,084,999 $ — $ 9.09 2.3 Shares authorized — — SARs granted (272,500) 272,500 7.26 SARs forfeited 282,500 (282,500) 7.84 SARs exercised — — — — Balances June 30, 2018 404,335 1,074,999 $ 79 $ 8.90 2.3 Shares authorized — — SARs granted (161,250) 161,250 8.17 SARs forfeited 250,833 (250,833) 10.59 SARs exercised — — — — Balances, June 29, 2019 493,918 985,416 $ — $ 8.35 1.7 Shares authorized — — SARs granted (175,000) 175,000 4.93 SARs forfeited 290,833 (290,833) 7.71 SARs exercised — — — — Balances, June 27, 2020 609,751 869,583 $ — $ 7.87 1.9 Exercisable at June 27, 2020 400,833 $ — $ 9.18 0.6 |
Additional Information Regarding Options Outstanding | Additional information regarding SARs outstanding and exercisable as of June 27, 2020, is as follows: Range of Number Outstanding Weighted Avg. Weighted Avg. Number Weighted $4.40 – $7.90 347,500 2.1 $ 6.25 — $ — 7.91 – 9.91 328,750 0.6 8.17 207,500 8.17 9.92 – 11.34 193,333 0.1 10.26 193,333 10.26 $4.40 to $11.34 869,583 1.9 $ 7.87 400,833 $ 9.18 |
DERIVATIVE FINANCIAL INSTRUME_2
DERIVATIVE FINANCIAL INSTRUMENTS (Tables) | 12 Months Ended |
Jun. 27, 2020 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Schedule of Derivative Instruments | As of June 27, 2020, the aggregate notional amount of the Company’s outstanding foreign currency contracts and swaps along with their unrealized gains (losses) are expected to mature as summarized below (in thousands): Quarter Ending Notional Contracts and Swaps in MXN Notional Contracts and Swaps in USD Estimated Fair Value September 26, 2020 $ 141,173 $ 6,729 $ (623) December 26, 2020 $ 132,773 $ 6,241 $ (561) April 3, 2021 $ 148,253 $ 6,682 $ (425) July 3, 2021 $ 144,725 $ 6,446 $ (367) October 2, 2021 $ 146,373 $ 5,502 $ 564 January 1, 2022 $ 137,973 $ 5,129 $ 532 |
Summerized Fair Value of Derivative Instruments in Consolidated Balance Sheets | The following table summarizes the fair value of derivative instruments in the Consolidated Balance Sheets as of June 27, 2020 and June 29, 2019 (in thousands): June 27, 2020 June 29, 2019 Derivatives Designated as Hedging Instruments Balance Sheet Location Fair Value Fair Value Foreign currency forward contracts & swaps Other current assets $ — $ 2,912 Foreign currency forward contracts & swaps Other long-term assets $ 1,097 $ 320 Foreign currency forward contracts & swaps Other current liabilities $ (1,960) $ — Foreign currency forward contracts & swaps Other long-term liabilities $ (17) $ — Interest rate swaps Other current assets $ — $ 2 Interest rate swaps Other current liabilities $ (347) $ — Interest rate swaps Other long-term liabilities $ (610) $ — |
Gain (Loss) of Derivative Instruments in Statement of Operations | The following table summarizes the gain (loss) on derivative instruments, net of tax, on the Consolidated Statements of Income for the fiscal year 2020 (in thousands): Derivatives Designated as Hedging Instruments Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) AOCI Balance Effective Effective Portion AOCI Balance Forward contracts & swaps Cost of sales $ 2,424 $ (865) $ (2,318) $ (759) Interest rate swap Interest expense 2 (782) 39 (741) Total $ 2,426 $ (1,647) $ (2,279) $ (1,500) The following table summarizes the gain (loss) on derivative instruments, net of tax, on the Consolidated Statements of Income for the fiscal year 2019 (in thousands): Derivatives Designated as Hedging Instruments Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) AOCI Balance Effective Effective Portion AOCI Balance Forward contracts & swaps Cost of sales $ (988) $ 3,332 $ 80 $ 2,424 Interest rate swap Interest expense 19 2 (19) 2 Total $ (969) $ 3,334 $ 61 $ 2,426 The following table summarizes the gain (loss) on derivative instruments, net of tax, on the Consolidated Statements of Income for the fiscal year 2018 (in thousands): Derivatives Designated as Hedging Instruments Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) AOCI Balance Effective Tax Rate Effect Reclassification Effective Portion AOCI Balance Forward contracts & swaps Cost of sales $ (2,707) $ (1,942) $ (583) $ 4,244 $ (988) Interest rate swap Interest expense (68) 20 (3) 70 19 Total $ (2,775) $ (1,922) $ (586) $ 4,314 $ (969) |
FAIR VALUE MEASUREMENTS (Tables
FAIR VALUE MEASUREMENTS (Tables) | 12 Months Ended |
Jun. 27, 2020 | |
Fair Value Disclosures [Abstract] | |
Assets and Liabilities Measured at Fair Value on Recurring Basis | The following table summarizes the fair value of assets (liabilities) of the Company’s derivatives that are required to be measured on a recurring basis as of June 27, 2020 and June 29, 2019 (in thousands): June 27, 2020 Level 1 Level 2 Level 3 Total Financial Assets: Foreign currency forward contracts & swaps $ — $ 1,097 $ — $ 1,097 Financial Liabilities: Interest rate swaps $ — $ (957) $ — $ (957) Foreign currency forward contracts & swaps $ — $ (1,977) $ — $ (1,977) June 29, 2019 Level 1 Level 2 Level 3 Total Financial Assets: Interest rate swaps $ — $ 2 $ — $ 2 Foreign currency forward contracts & swaps — 3,232 — $ 3,232 |
ENTERPRISE-WIDE DISCLOSURES (Ta
ENTERPRISE-WIDE DISCLOSURES (Tables) | 12 Months Ended |
Jun. 27, 2020 | |
Segment Reporting [Abstract] | |
Net Sales and Long-Lived Assets (Property, Plant, and Equipment) by Geographic Area | Net sales and long-lived assets (property, plant, and equipment) by geographic area for the years ended and as of June 27, 2020, June 29, 2019 and June 30, 2018 are summarized in the following table. Net sales set forth below are based on the shipping destination. Long-lived assets information is based on the physical location of the asset. Fiscal Year Ended (in thousands) 2020 2019 2018 Geographic net sales: Domestic (U.S.) $ 338,766 $ 357,341 $ 329,230 Foreign 110,714 106,703 117,092 Total $ 449,480 $ 464,044 $ 446,322 Long-lived assets: United States $ 9,213 $ 9,658 $ 7,454 Mexico 19,325 17,781 19,395 Vietnam 2,644 1,220 — China 582 754 699 Total $ 31,764 $ 29,413 $ 27,548 |
Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area | Percentage of net sales made to customers located in the following countries: Fiscal Year Ended 2020 2019 2018 United States 75% 77% 74% China 19 19 24 Other foreign countries (a) 5 3 2 Canada 1 1 — Total 100% 100% 100% (a) No other individual foreign country accounted for 10% or more of the foreign sales in fiscal years 2020, 2019 or 2018. |
Percentage of Net Sales to and Trade Accounts Receivables from Significant Customers | The percentage of net sales to and trade accounts receivables from significant customers were as follows: Percentage of Net Percentage of 2020 2019 2018 2020 2019 Customer A 18% 17% 19% 14% 11% Customer B * * * 12 % * |
QUARTERLY FINANCIAL DATA (Table
QUARTERLY FINANCIAL DATA (Tables) | 12 Months Ended |
Jun. 27, 2020 | |
Quarterly Financial Information Disclosure [Abstract] | |
Quarterly Financial Data | QUARTERLY FINANCIAL DATA (Unaudited) Fiscal Year Ended June 27, 2020 First Second Third Fourth (in thousands, except per share amounts) Net sales $ 105,285 $ 116,722 $ 111,455 $ 116,018 Gross profit 9,273 8,122 9,248 8,606 Income before income taxes 1,829 974 1,010 506 Net income 1,552 824 910 1,472 Net income per share - basic $ 0.14 $ 0.08 $ 0.08 $ 0.14 Net income per share - diluted $ 0.14 $ 0.08 $ 0.08 $ 0.14 Weighted average shares outstanding Basic 10,760 10,760 10,760 10,760 Diluted 10,805 10,877 10,885 10,832 Fiscal Year Ended June 29, 2019 First Second Third Fourth (in thousands, except per share amounts) Net sales $ 127,472 $ 123,037 $ 107,954 $ 105,581 Gross profit 9,533 9,880 6,807 8,381 Income (loss) before income taxes 1,868 1,916 (13,256) 732 Net income (loss) 1,593 1,589 (11,981) 817 Net income (loss) per share - basic $ 0.15 $ 0.15 $ (1.11) $ 0.08 Net income (loss) per share - diluted $ 0.15 $ 0.15 $ (1.11) $ 0.08 Weighted average shares outstanding Basic 10,760 10,760 10,760 10,760 Diluted 10,979 10,881 10,760 10,760 |
GOODWILL AND OTHER INTANGIBLES
GOODWILL AND OTHER INTANGIBLES ASSETS (Tables) | 12 Months Ended |
Jun. 27, 2020 | |
GOODWILL AND OTHER INTANGIBLE ASSETS [Abstract] | |
Schedule of Finite-Lived Intangible Assets | The components of acquired intangible assets are as follows (in thousands): June 27, 2020 Amortization Period Gross Carrying Accumulated Derecognition Favorable Lease per ASC 842 Net Carrying Other intangible assets: Favorable Lease Agreements 4 - 7 2,941 (2,284) (657) — Total $ 2,941 $ (2,284) $ (657) $ — June 29, 2019 Amortization Period Gross Carrying Accumulated Impairment Net Carrying Other intangible assets: Non-Compete Agreements 3 - 5 $ 568 $ (568) $ — $ — Customer Relationships 10 4,803 (2,311) (2,492) — Favorable Lease Agreements 4 - 7 2,941 (2,284) — 657 Total $ 8,312 $ (5,163) $ (2,492) $ 657 |
REVENUE (Tables)
REVENUE (Tables) | 12 Months Ended |
Jun. 27, 2020 | |
Revenue from Contract with Customer [Abstract] | |
Contract with Customer, Contract Asset, Contract Liability, and Receivable | REVENUE Revenue Recognition The Company specializes in services ranging from product manufacturing to engineering and tooling services. The first step in its process for revenue recognition is to identify the contract with a customer. A contract is defined as an agreement between two or more parties that creates enforceable rights and obligations. A contract can be written, oral, or implied. The Company generally enters into manufacturing service agreements (“MSA”) with its customers that outlines the terms of the business relationship between the customer and the Company. This includes matters such as warranty, indemnification, transfer of title and risk of loss, liability for excess and obsolete inventory, pricing, payment terms, etc. The Company will also bid on a program-by-program basis for customers in which an executed MSA may not be in place. In these instances, as well as when we have an MSA in place, we receive customer purchase orders for specific quantities and timing of products. As a result, the Company considers its contract with a customer to be the combination of the MSA and the purchase order. The transaction price is fixed and set forth in each purchase order. In the Company's normal course of business, there are no variable pricing components, or material amounts refunded to customers in the form of refunds or rebates. The Company assesses whether control of the product or services promised under the contract is transferred to the customer at a point in time (shipment) or over time (as we manufacture the product). The Company is first required to evaluate whether its contracts meet the criteria for 'over-time' or 'point-in-time' recognition. The Company has determined that for the majority of its contracts the Company is manufacturing products for which there is no alternative use due to the unique nature of the customer-specific product, IP and other contract restrictions. The Company has an enforceable right to payment including a reasonable profit for performance completed to date with respect to these contracts. As a result, revenue is recognized under these contracts 'over-time' based on the input cost-to-cost method as it better depicts the transfer of control. This input method is based on the ratio of costs incurred to date as compared to the total estimated costs at completion of the performance obligation. For all other contracts that do not meet these criteria, such as manufacturing contracts for which the terms do not provide an enforceable right to payment for performance completed to date, the Company recognizes revenue when it has transferred control of the related manufactured products which generally occurs upon shipment to the customer. Revenue from engineering services is recognized over time as the services are performed. The Company’s typical payment terms are 30 to 45 days and its sales arrangements do not contain any significant financing component for its customers. The Company generally provides a warranty for workmanship on its manufacturing contracts. Historically, the amount of returns for workmanship issues has been de minimis under the Company’s warranties. The Company elected to not disclose information about remaining performance obligations as they are part of contracts that that have expected durations of one year or less. The Company has elected to expense costs to obtain contracts as incurred as these costs are immaterial to the financial statements. During fiscal 2020, no revenues were recognized from performance obligations satisfied or partially satisfied in previous periods. Contract Balances A contract asset is recognized when the Company has recognized revenue, but has not issued an invoice for payment. Contract assets are classified separately on the condensed consolidated balance sheet and transferred to receivables when the right to payment becomes unconditional. The following table summarizes the activity in the Company’s contract assets during the twelve months ended June 27, 2020 (in thousands): Contract Assets Beginning balance, June 29, 2019 $ 22,161 Revenue recognized 441,405 Amounts collected or invoiced (439,813) Ending balance, June 27, 2020 $ 23,753 The following table summarizes the activity in the Company’s contract assets during the twelve months ended June 29, 2019 (in thousands): Contract Assets Beginning balance, June 30, 2018 — Cumulative effect adjustment at July 1, 2018 11,906 Revenue recognized 448,003 Amounts collected or invoiced (437,748) Ending balance, June 29, 2019 $ 22,161 Disaggregation of Revenue The following table presents the Company’s revenue disaggregated for the twelve months ended June 27, 2020 and the twelve months ended June 29, 21019 (in thousands): Revenue Recognition June 27, 2020 June 29, 2019 Over-Time $ 441,405 $ 458,256 Point-in-Time 8,075 5,788 Total $ 449,480 $ 464,044 Revenues and associated costs from engineering design, development services and tooling, which are performed under contract of short term durations, are recognized over time as the services are performed. Revenue from engineering design, development services and tooling represented approximately 3.3% of total revenue in fiscal year 2020. |
Disaggregation of Revenue | The following table presents the Company’s revenue disaggregated for the twelve months ended June 27, 2020 and the twelve months ended June 29, 21019 (in thousands): Revenue Recognition June 27, 2020 June 29, 2019 Over-Time $ 441,405 $ 458,256 Point-in-Time 8,075 5,788 Total $ 449,480 $ 464,044 |
LEASES (Tables)
LEASES (Tables) | 12 Months Ended |
Jun. 27, 2020 | |
Leases [Abstract] | |
Lease, Cost | The components of lease cost as of June 27, 2020 were (in thousands): Year Ended Lease cost Classification June 27, 2020 Operating lease cost Cost of sales $ 4,511 Operating lease cost Selling, general and administrative expenses 1,266 Total lease cost $ 5,777 |
Lessee, Operating Lease, Disclosure | Amounts reported in the Consolidated Balance Sheet as of June 27, 2020 were (in thousands, except weighted average lease term and discount rate): June 27, 2020 Operating Leases: Operating lease right of use assets $ 17,568 Operating lease liabilities (1) 17,173 Weighted-average remaining lease term (in years) Operating leases 6.46 Weighted-average discount rate Operating leases 4.07 % (1) The current portion of the total operating lease liabilities of $4.5 million is classified under Other Current Liabilities, resulting in $12.6 million classified under Operating Lease Liabilities in the Long-term Liabilities section of the consolidated balance sheet. Other information related to leases was as follows (in thousands): June 27, 2020 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases 4,237 |
Lessee, Operating Lease, Liability, Maturity | Future lease payments under non-cancellable leases as of June 27, 2020 are as follows (in thousands): Fiscal Years Ending Operating Leases 2021 $ 4,250 2022 3,373 2023 2,598 2024 2,004 2025 1,894 Thereafter 5,674 Total undiscounted lease payments 19,793 Less: present value discount 2,620 Total lease liabilities $ 17,173 |
Schedule of Future Minimum Rental Payments for Operating Leases | As previously disclosed in our Annual Report on Form 10-K for the fiscal year ended June 29, 2019 and under the previous lease accounting standard ASC 840, the aggregate future minimum payments under non-cancellable operating leases, as of June 29, 2019, are as follows (in thousands): Fiscal Years Ending Operating Leases 2020 $ 4,777 2021 3,563 2022 2,641 2023 1,866 2024 1,271 Thereafter 4,121 Total minimum lease payments $ 18,239 |
Significant Accounting Polici_3
Significant Accounting Policies (Narrative) (Detail) - USD ($) | 12 Months Ended | ||||||
Jun. 27, 2020 | Sep. 05, 2019 | Jun. 29, 2019 | Sep. 29, 2018 | Jul. 01, 2018 | Jun. 30, 2018 | Dec. 28, 2016 | |
Debt Disclosure [Line Items] | |||||||
Retained earnings | $ 70,111,000 | $ 65,353,000 | $ 73,335,000 | $ 72,806,000 | |||
Percentage Of Expected Over Aggregate Annual Insurance Claims | 125.00% | ||||||
Maximum Amount Of Income Tax Benefits Percentage Realized Upon Ultimate Settlement | 50.00% | ||||||
Revolving loan | $ 60,094,000 | 23,356,000 | |||||
Long-term Debt | 70,935,000 | $ 5,000,000 | $ 35,000,000 | ||||
Difference between Revenue Guidance in Effect before and after Topic 606 | |||||||
Debt Disclosure [Line Items] | |||||||
Retained earnings | 2,431,000 | $ 529,000 | |||||
Calculated under Revenue Guidance in Effect before Topic 606 | |||||||
Debt Disclosure [Line Items] | |||||||
Retained earnings | 62,922,000 | ||||||
Long-term Debt | |||||||
Debt Disclosure [Line Items] | |||||||
Long-term Debt | 10,000,000 | 11,300,000 | |||||
Equipment Term Loan | |||||||
Debt Disclosure [Line Items] | |||||||
Long-term Debt | $ 900,000 | $ 1,700,000 | $ 3,900,000 |
SIGNIFICANT ACCOUNTING POLICI_4
SIGNIFICANT ACCOUNTING POLICIES (Revenue, Initial Application Period Cumulative Effect Transition) (Detail) - USD ($) | 3 Months Ended | 12 Months Ended | ||||||||||
Jun. 27, 2020 | Mar. 28, 2020 | Dec. 28, 2019 | Sep. 28, 2019 | Jun. 29, 2019 | Mar. 30, 2019 | Dec. 29, 2018 | Sep. 29, 2018 | Jun. 27, 2020 | Jun. 29, 2019 | Jun. 30, 2018 | Jul. 01, 2018 | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | ||||||||||||
Contract assets | $ 23,753,000 | $ 22,161,000 | $ 23,753,000 | $ 22,161,000 | $ 0 | $ 11,906,000 | ||||||
Inventories, net | 115,020,000 | 100,431,000 | 115,020,000 | 100,431,000 | 110,315,000 | 99,105,000 | ||||||
Deferred Tax Assets, Net, Noncurrent | 7,840,000 | 7,840,000 | 7,882,000 | 7,715,000 | ||||||||
Retained earnings | 70,111,000 | 65,353,000 | 70,111,000 | 65,353,000 | 72,806,000 | 73,335,000 | ||||||
Revenues | 116,018,000 | $ 111,455,000 | $ 116,722,000 | $ 105,285,000 | 105,581,000 | $ 107,954,000 | $ 123,037,000 | $ 127,472,000 | 449,480,000 | 464,044,000 | 446,322,000 | |
Cost of Goods and Services Sold | 414,231,000 | 429,443,000 | 412,153,000 | |||||||||
Gross profit | 8,606,000 | 9,248,000 | 8,122,000 | 9,273,000 | 8,381,000 | 6,807,000 | 9,880,000 | 9,533,000 | 35,249,000 | 34,601,000 | 34,169,000 | |
Net income (loss) | $ 1,472,000 | $ 910,000 | $ 824,000 | $ 1,552,000 | 817,000 | $ (11,981,000) | $ 1,589,000 | $ 1,593,000 | $ 4,758,000 | (7,982,000) | $ (1,325,000) | |
Difference between Revenue Guidance in Effect before and after Topic 606 | ||||||||||||
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | ||||||||||||
Contract assets | (22,161,000) | (22,161,000) | 11,906,000 | |||||||||
Inventories, net | 19,563,000 | 19,563,000 | (11,210,000) | |||||||||
Deferred Tax Assets, Net, Noncurrent | 167,000 | 167,000 | (167,000) | |||||||||
Retained earnings | 2,431,000 | 2,431,000 | $ 529,000 | |||||||||
Revenues | 10,254,000 | |||||||||||
Cost of Goods and Services Sold | 8,353,000 | |||||||||||
Gross profit | 1,901,000 | |||||||||||
Net income (loss) | 1,901,000 | |||||||||||
Calculated under Revenue Guidance in Effect before Topic 606 | ||||||||||||
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | ||||||||||||
Contract assets | 0 | 0 | ||||||||||
Inventories, net | 119,994,000 | 119,994,000 | ||||||||||
Deferred Tax Assets, Net, Noncurrent | 8,007,000 | 8,007,000 | ||||||||||
Retained earnings | $ 62,922,000 | 62,922,000 | ||||||||||
Revenues | 453,790,000 | |||||||||||
Cost of Goods and Services Sold | 421,090,000 | |||||||||||
Gross profit | 32,700,000 | |||||||||||
Net income (loss) | $ (9,883,000) |
Inventories (Components Of Inve
Inventories (Components Of Inventories) (Detail) - USD ($) | Jun. 27, 2020 | Jun. 29, 2019 | Jul. 01, 2018 | Jun. 30, 2018 |
Inventory [Line Items] | ||||
Inventory Valuation Reserves | $ 17,300,000 | $ 10,800,000 | ||
Finished goods | 15,269,000 | 11,969,000 | ||
Work-in-process | 17,390,000 | 11,705,000 | ||
Raw materials and supplies | 82,361,000 | 76,757,000 | ||
Inventories | $ 115,020,000 | $ 100,431,000 | $ 99,105,000 | $ 110,315,000 |
Property Plant And Equipment (S
Property Plant And Equipment (Schedule Of Property Plant And Equipment) (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 27, 2020 | Jun. 29, 2019 | Jun. 30, 2018 | |
Property, Plant and Equipment [Line Items] | |||
Land | $ 4,034 | $ 2,940 | |
Buildings and improvements | 23,444 | 23,776 | |
Equipment | 72,151 | 67,348 | |
Furniture and fixtures | 4,883 | 4,248 | |
Total Property, Plant and Equipment | 104,512 | 98,312 | |
Accumulated depreciation | (72,748) | (68,899) | |
Property, plant and equipment, net | $ 31,764 | $ 29,413 | $ 27,548 |
Buildings and improvements | Minimum | |||
Property, Plant and Equipment [Line Items] | |||
Property, Plant and Equipment, Useful Life | 3 years | ||
Buildings and improvements | Maximum | |||
Property, Plant and Equipment [Line Items] | |||
Property, Plant and Equipment, Useful Life | 30 years | ||
Equipment | Minimum | |||
Property, Plant and Equipment [Line Items] | |||
Property, Plant and Equipment, Useful Life | 1 year | ||
Equipment | Maximum | |||
Property, Plant and Equipment [Line Items] | |||
Property, Plant and Equipment, Useful Life | 10 years | ||
Furniture and fixtures | Minimum | |||
Property, Plant and Equipment [Line Items] | |||
Property, Plant and Equipment, Useful Life | 3 years | ||
Furniture and fixtures | Maximum | |||
Property, Plant and Equipment [Line Items] | |||
Property, Plant and Equipment, Useful Life | 5 years |
Long-Term Debt (Narrative) (Det
Long-Term Debt (Narrative) (Detail) - USD ($) | 3 Months Ended | 12 Months Ended | ||||||
Jun. 27, 2020 | Jun. 27, 2020 | Jun. 29, 2019 | Mar. 05, 2020 | Nov. 20, 2019 | Sep. 05, 2019 | Sep. 29, 2018 | Dec. 28, 2016 | |
Debt Disclosure [Line Items] | ||||||||
Revolving loan | $ 60,094,000 | $ 60,094,000 | $ 23,356,000 | |||||
Letters of Credit Outstanding, Amount | 400,000 | 400,000 | 400,000 | |||||
Additional availability of line of credit | 4,500,000 | 4,500,000 | 21,300,000 | |||||
Long-term Debt | 70,935,000 | 70,935,000 | $ 5,000,000 | $ 35,000,000 | ||||
Debt Instrument, Periodic Payment, Principal | 400,000 | $ 1,670,000 | ||||||
Debt Instrument, Basis Spread on Variable Rate | 2.00% | |||||||
2021 | 7,537,000 | $ 7,537,000 | ||||||
2022 | 2,917,000 | 2,917,000 | ||||||
2023 | 417,000 | 417,000 | ||||||
2024 | 60,094,000 | 60,094,000 | ||||||
Total debt | 70,965,000 | 70,965,000 | ||||||
Unamortized debt issuance costs | (30,000) | (30,000) | ||||||
Long-term Debt | ||||||||
Debt Disclosure [Line Items] | ||||||||
Long-term Debt | 10,000,000 | 10,000,000 | 11,300,000 | |||||
Equipment Term Loan | ||||||||
Debt Disclosure [Line Items] | ||||||||
Long-term Debt | $ 900,000 | 900,000 | $ 1,700,000 | $ 3,900,000 | ||||
Debt Instrument, Periodic Payment, Principal | $ 200,000 | |||||||
Wells Fargo Bank | ||||||||
Debt Disclosure [Line Items] | ||||||||
Increase in revolving line of credit | $ 65,000,000 | $ 55,000,000 | ||||||
Maximum | ||||||||
Debt Disclosure [Line Items] | ||||||||
Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate | 2.18% | 2.18% | 5.50% | |||||
Minimum | ||||||||
Debt Disclosure [Line Items] | ||||||||
Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate | 2.17% | 2.17% | 4.40% | |||||
One-Month London Interbank Offered Rate [Member] | Line of Credit | ||||||||
Debt Disclosure [Line Items] | ||||||||
Debt Instrument, Basis Spread on Variable Rate | 1.50% | |||||||
Federal Funds Rate [Member] | Line of Credit | ||||||||
Debt Disclosure [Line Items] | ||||||||
Debt Instrument, Basis Spread on Variable Rate | 1.50% | |||||||
Fixed Rate [Member] | Debt Instrument, Basis Spread on Variable Rate, Scenario One [Member] | Line of Credit | ||||||||
Debt Disclosure [Line Items] | ||||||||
Debt Instrument, Basis Spread on Variable Rate | 1.75% | |||||||
Fixed Rate [Member] | Debt Instrument, Basis Spread on Variable Rate, Scenario Two [Member] | Line of Credit | Line of Credit | ||||||||
Debt Disclosure [Line Items] | ||||||||
Debt Instrument, Basis Spread on Variable Rate | 2.00% | |||||||
Fixed Rate [Member] | Debt Instrument, Basis Spread on Variable Rate, Scenario Three [Member] | Line of Credit | Line of Credit | ||||||||
Debt Disclosure [Line Items] | ||||||||
Debt Instrument, Basis Spread on Variable Rate | 2.25% |
Trade Accounts Receivable Purch
Trade Accounts Receivable Purchase Programs (Detail) - USD ($) $ in Thousands | 12 Months Ended | |
Jun. 27, 2020 | Jun. 29, 2019 | |
Receivables [Abstract] | ||
Account Purchase Agreement Maximum Aggregate Amount | $ 25,000 | |
Trade Accounts Receivable Sold To Third Party | 41,400 | $ 81,000 |
Accounts Receivable Factored To Banking Institutions and not yet collected | $ 9 | $ 1,700 |
Income Taxes (Narrative) (Detai
Income Taxes (Narrative) (Detail) - USD ($) | 12 Months Ended | |||
Jun. 27, 2020 | Jun. 29, 2019 | Jun. 30, 2018 | Jul. 01, 2017 | |
Income Tax Disclosure [Abstract] | ||||
Tax Credit Carryforwards | $ 8,800,000 | |||
Toll Tax Liability | 800,000 | |||
Toll Tax Liability, Change in Amount | 400,000 | |||
Other Tax Expense (Benefit) | 1,300,000 | |||
Current Income Tax Expense (Benefit) | 1,300,000 | |||
Estimated Federal And State Income Taxes And Potential Withholding Taxes | 800,000 | |||
Effect of repatriation of foreign earnings, net | 7,800,000 | |||
Deferred Tax Assets, Tax Credit Carryforwards, Research | $ 8,800,000 | |||
Remaining Contractual Term Of Tax Credit Expiration Date | 20 years | |||
Deferred Tax Assets, Tax Credit Carryforwards, Alternative Minimum Tax | $ 347,000 | |||
Previously unrecognized tax benefits | $ 2,863,000 | $ 4,099,000 | $ 4,011,000 | $ 3,947,000 |
Income Tax (Income Tax Expense
Income Tax (Income Tax Expense (Benefit)) (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 27, 2020 | Jun. 29, 2019 | Jun. 30, 2018 | |
Income Tax Disclosure [Abstract] | |||
United States | $ 365 | $ (537) | $ (221) |
Foreign | 154 | 895 | 1,722 |
Current Income Tax Expense (Benefit) | 519 | 358 | 1,501 |
United States | (1,850) | (910) | (795) |
Foreign | 892 | (206) | (823) |
Deferred Income Tax Expense (Benefit) | (958) | (1,116) | (1,618) |
Total income tax benefit | $ (439) | $ (758) | $ (117) |
Income Taxes (Effective Tax Rat
Income Taxes (Effective Tax Rate Reconciliation) (Detail) - USD ($) | 12 Months Ended | ||
Jun. 27, 2020 | Jun. 29, 2019 | Jun. 30, 2018 | |
Income Tax Disclosure [Abstract] | |||
Federal income tax provision (benefit) at statutory rates | $ 907,000 | $ (1,836,000) | $ (397,000) |
State income taxes, net of federal tax effect | 90,000 | (158,000) | (4,000) |
Foreign tax rate differences | 336,000 | 251,000 | 103,000 |
Tax rate change | 0 | 0 | 1,634,000 |
Provisional transition tax on accumulated foreign earnings | 0 | (384,000) | 1,190,000 |
Effect of income tax credits | (310,000) | (861,000) | (687,000) |
Previously unrecognized tax benefits | (1,345,000) | 0 | 0 |
Effect of repatriation of foreign earnings, net | 0 | (42,000) | (1,484,000) |
Goodwill write-off | 0 | 1,726,000 | 0 |
Global Intangible Low-Taxed Income (GILTI) tax | 0 | 150,000 | 0 |
Provision to return reconciliation | (241,000) | 630,000 | (401,000) |
Other | 124,000 | (234,000) | (71,000) |
Total income tax benefit | $ (439,000) | $ (758,000) | $ (117,000) |
Income Taxes (Components Of Inc
Income Taxes (Components Of Income before Income Taxes) (Detail) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||||
Jun. 27, 2020 | Mar. 28, 2020 | Dec. 28, 2019 | Sep. 28, 2019 | Jun. 29, 2019 | Mar. 30, 2019 | Dec. 29, 2018 | Sep. 29, 2018 | Jun. 27, 2020 | Jun. 29, 2019 | Jun. 30, 2018 | |
Income Tax Disclosure [Abstract] | |||||||||||
Domestic | $ 1,142 | $ (12,220) | $ (4,593) | ||||||||
Foreign | 3,177 | 3,480 | 3,151 | ||||||||
Income (loss) before income taxes | $ 506 | $ 1,010 | $ 974 | $ 1,829 | $ 732 | $ (13,256) | $ 1,916 | $ 1,868 | $ 4,319 | $ (8,740) | $ (1,442) |
Income Taxes (Deferred Income T
Income Taxes (Deferred Income Tax Assets And Liabilities) (Detail) - USD ($) $ in Thousands | Jun. 27, 2020 | Jun. 29, 2019 |
Income Tax Disclosure [Abstract] | ||
Net operating loss | $ 184 | $ 33 |
Tax credit carryforwards, net | 5,961 | 4,986 |
Inventory | 1,426 | 1,087 |
Identifiable intangibles | 493 | 407 |
Interest expense carryforward | 0 | 474 |
Accruals | 2,847 | 3,549 |
Research and development expenses | 0 | 232 |
Mart-to-market adjustments | 415 | 0 |
ASC 606 deferred costs | 1,943 | 2,484 |
Deferred Tax Assets, Lease Liability | 3,201 | 0 |
Other | 212 | 30 |
Deferred income tax assets | 16,682 | 13,282 |
Accrued withholding tax - unremitted earnings | (820) | (820) |
Fixed assets | (566) | (443) |
Deferred Tax Liabilities, Leasing Arrangements | (3,290) | 0 |
Mart-to-market adjustments | 0 | (730) |
ASC 606 accelerated revenue | (1,344) | 3,274 |
Other | (718) | (175) |
Deferred income tax liabilities | 6,738 | 5,442 |
Net deferred income tax assets | 9,944 | 7,840 |
Deferred income tax asset | 10,178 | 7,840 |
Deferred income tax liability | $ (234) | $ 0 |
Income Taxes (Schedule Of Unrec
Income Taxes (Schedule Of Unrecognized Tax Benefits) (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 27, 2020 | Jun. 29, 2019 | Jun. 30, 2018 | |
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] | |||
Balances, beginning of period | $ 4,099 | $ 4,011 | $ 3,947 |
Additions based on tax positions related to the current year | 109 | 88 | 64 |
Lapse of statute of limitations | (1,345) | 0 | 0 |
Balances, end of period | $ 2,863 | $ 4,099 | $ 4,011 |
Earnings Per Share (Reconciliat
Earnings Per Share (Reconciliation Of Denominator And Number Of Antidilutive Common Share Awards Not Included In Diluted Earnings Per Share Calculation) (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||||
Jun. 27, 2020 | Mar. 28, 2020 | Dec. 28, 2019 | Sep. 28, 2019 | Jun. 29, 2019 | Mar. 30, 2019 | Dec. 29, 2018 | Sep. 29, 2018 | Jun. 27, 2020 | Jun. 29, 2019 | Jun. 30, 2018 | |
Earnings Per Share [Abstract] | |||||||||||
Net income (loss) | $ 1,472 | $ 910 | $ 824 | $ 1,552 | $ 817 | $ (11,981) | $ 1,589 | $ 1,593 | $ 4,758 | $ (7,982) | $ (1,325) |
Weighted average shares outstanding– basic | 10,760 | 10,760 | 10,760 | 10,760 | 10,760 | 10,760 | 10,760 | 10,760 | 10,760 | 10,760 | 10,760 |
Effect of dilutive common stock awards | 57 | 0 | 0 | ||||||||
Weighted average shares outstanding – diluted | 10,832 | 10,885 | 10,877 | 10,805 | 10,760 | 10,760 | 10,881 | 10,979 | 10,816 | 10,760 | 10,760 |
Earnings per share – basic (in dollars per share) | $ 0.14 | $ 0.08 | $ 0.08 | $ 0.14 | $ 0.08 | $ (1.11) | $ 0.15 | $ 0.15 | $ 0.44 | $ (0.74) | $ (0.12) |
Earnings per share – diluted (in dollars per share) | $ 0.14 | $ 0.08 | $ 0.08 | $ 0.14 | $ 0.08 | $ (1.11) | $ 0.15 | $ 0.15 | $ 0.44 | $ (0.74) | $ (0.12) |
Antidilutive SARs not included in diluted earnings per share | 720 | 985 | 827 |
Stock Option And Benefit Plan_2
Stock Option And Benefit Plans (Narrative) (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Jun. 27, 2020 | Jun. 29, 2019 | Jun. 30, 2018 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Stock-based compensation expense | $ 0.3 | $ 0.4 | $ 0.4 |
Unrecognized share based compensation expense | $ 0.2 | ||
Share Based Expense Recognition - Weighted-average period | 1 year 6 months 29 days | ||
Company contributions to 401K | $ 0.8 | $ 0.9 | $ 0.8 |
Stock Option And Benefit Plan_3
Stock Option And Benefit Plans (Grant Date Fair Value For Awards Estimated Using Option Valuation Method With Weighted Average Assumptions) (Detail) - Number of Options/SARs Outstanding | Jul. 27, 2019 | Jul. 27, 2018 | Jul. 28, 2017 |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Expected dividend yield | 0.00% | 0.00% | 0.00% |
Risk – free interest rate | 1.54% | 2.80% | 1.70% |
Expected volatility | 28.50% | 29.75% | 29.76% |
Expected life | 4 years | 4 years | 4 years |
Stock Option And Benefit Plan_4
Stock Option And Benefit Plans (Summarizes Option/SARs Activity Of All Plans) (Detail) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | ||||
Jun. 27, 2020 | Jun. 29, 2019 | Jun. 30, 2018 | Jul. 02, 2016 | Jul. 01, 2017 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Balances, June 29, 2019 | 609,751 | 493,918 | 404,335 | 394,335 | |
Balances, June 27, 2020 | 609,751 | 493,918 | 404,335 | 394,335 | |
Shares authorized | 0 | 0 | 0 | ||
SARs granted | (175,000) | (161,250) | (272,500) | ||
SARs forfeited | (290,833) | (250,833) | (282,500) | ||
Aggregate Intrinsic Value, Beginning balance | $ 0 | $ 79 | $ 0 | ||
Intrinsic value for options exercised | 0 | 0 | 0 | ||
Aggregate Intrinsic Value, Ending balance | 0 | $ 0 | $ 79 | ||
Aggregate Intrinsic Value, Exercisable | $ 0 | ||||
Outstanding, Beginning balance | $ 8.35 | $ 8.90 | $ 9.09 | ||
SARs Granted Weighted Average Exercise Price | 4.93 | 8.17 | 7.26 | ||
SARs Forfeitures and Expirations in Period, Weighted Average Exercise Price | 7.71 | 10.59 | 7.84 | ||
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | 0 | 0 | 0 | ||
Outstanding, Ending balance | 7.87 | $ 8.35 | $ 8.90 | ||
Weighted Average Exercise Price, Exercisable | $ 9.18 | ||||
Weighted Average Remaining Contractual Life (in years), Outstanding | 1 year 10 months 24 days | 1 year 8 months 12 days | 2 years 3 months 18 days | 2 years 3 months 18 days | |
Weighted Average Remaining Contractual Life (in years), Outstanding | 1 year 10 months 24 days | 1 year 8 months 12 days | 2 years 3 months 18 days | 2 years 3 months 18 days | |
Weighted Average Remaining Contractual Life (in years), Exercisable | 7 months 6 days | ||||
Number of Options/SARs Outstanding | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Beginning balance | 985,416 | 1,074,999 | 1,084,999 | ||
Shares authorized | |||||
SARs granted | (175,000) | (161,250) | (272,500) | ||
SARs forfeited | (290,833) | (250,833) | (282,500) | ||
SARs exercised | 0 | 0 | 0 | ||
Ending balance | 869,583 | 985,416 | 1,074,999 | ||
Exercisable at June 27, 2020 | 400,833 |
Stock Option And Benefit Plan_5
Stock Option And Benefit Plans (Additional Information Regarding Options Outstanding) (Detail) | 12 Months Ended |
Jun. 27, 2020$ / sharesshares | |
$4.40 to $7.90 | |
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | |
Range of Exercise Prices | $ 4.40 |
Range of Exercise Prices | $ 7.90 |
Number Outstanding | shares | 347,500 |
SARs Outstanding Weighted Avg. Remaining Contractual Life (yrs.) | 2 years 1 month 6 days |
Weighted Avg. Exercise Price | $ 6.25 |
SARs Exercisable Number Exercisable | shares | 0 |
Weighted Avg. Exercise Price | $ 0 |
$7.91 to $9.91 | |
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | |
Range of Exercise Prices | 7.91 |
Range of Exercise Prices | $ 9.91 |
Number Outstanding | shares | 328,750 |
SARs Outstanding Weighted Avg. Remaining Contractual Life (yrs.) | 7 months 6 days |
Weighted Avg. Exercise Price | $ 8.17 |
SARs Exercisable Number Exercisable | shares | 207,500 |
Weighted Avg. Exercise Price | $ 8.17 |
$9.92 to $11.34 | |
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | |
Range of Exercise Prices | 9.92 |
Range of Exercise Prices | $ 11.34 |
Number Outstanding | shares | 193,333 |
SARs Outstanding Weighted Avg. Remaining Contractual Life (yrs.) | 1 month 6 days |
Weighted Avg. Exercise Price | $ 10.26 |
SARs Exercisable Number Exercisable | shares | 193,333 |
Weighted Avg. Exercise Price | $ 10.26 |
$4.40 to $11.34 | |
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | |
Range of Exercise Prices | 4.40 |
Range of Exercise Prices | $ 11.34 |
Number Outstanding | shares | 869,583 |
SARs Outstanding Weighted Avg. Remaining Contractual Life (yrs.) | 1 year 10 months 24 days |
Weighted Avg. Exercise Price | $ 7.87 |
SARs Exercisable Number Exercisable | shares | 400,833 |
Weighted Avg. Exercise Price | $ 9.18 |
Commitments And Contingencies (
Commitments And Contingencies (Narrative) (Detail) - USD ($) | 12 Months Ended | ||
Jun. 27, 2020 | Jun. 29, 2019 | Jun. 30, 2018 | |
Commitments and Contingencies Disclosure [Abstract] | |||
Operating Leases, Rent Expense, Net | $ 4,200,000 | $ 5,000,000 | $ 7,100,000 |
Standard and Extended Product Warranty Accrual | $ 15,000 | $ 22,000 |
Derivative Financial Instrume_3
Derivative Financial Instruments (Detail) - USD ($) | 12 Months Ended | |||
Jun. 27, 2020 | Jun. 29, 2019 | Jun. 30, 2018 | Nov. 06, 2019 | |
Derivative [Line Items] | ||||
Derivative, Notional Amount | $ 11,700,000 | $ 15,000,000 | ||
Net amount of existing losses expected to be reclassified into earnings within the next 12 months | 1,800,000 | |||
Foreign currency forward contracts entered | 23,800,000 | $ 19,200,000 | $ 13,700,000 | |
Foreign currency forward contracts settled | $ 26,700,000 | $ 25,900,000 | $ 28,100,000 | |
Derivative, Fixed Interest Rate | 1.70% | |||
Line of Credit | ||||
Derivative [Line Items] | ||||
Derivative, Fixed Interest Rate | 1.67% | |||
Forward Contracts & swaps | ||||
Derivative [Line Items] | ||||
Derivative, Notional Amount | $ 36,700,000 |
Schedule of Derivative Instrume
Schedule of Derivative Instruments (Detail) - USD ($) $ in Thousands | Jan. 01, 2022 | Oct. 02, 2021 | Jul. 03, 2021 | Apr. 03, 2021 | Dec. 26, 2020 | Sep. 26, 2020 | Jun. 27, 2020 | Nov. 06, 2019 |
Derivative [Line Items] | ||||||||
Derivative, Notional Amount | $ 11,700 | $ 15,000 | ||||||
Subsequent Event | ||||||||
Derivative [Line Items] | ||||||||
Derivative, Fair Value, Net | $ 532 | $ 564 | $ (367) | $ (425) | $ (561) | $ (623) | ||
Subsequent Event | Mexico, Pesos | ||||||||
Derivative [Line Items] | ||||||||
Derivative, Notional Amount | 137,973 | 146,373 | 144,725 | 148,253 | 132,773 | 141,173 | ||
Subsequent Event | United States of America, Dollars | ||||||||
Derivative [Line Items] | ||||||||
Derivative, Notional Amount | $ 5,129 | $ 5,502 | $ 6,446 | $ 6,682 | $ 6,241 | $ 6,729 |
Derivative Financial Instrume_4
Derivative Financial Instruments (Summarized Fair Value Of Derivative Instruments In Consolidated Balance Sheets) (Detail) - USD ($) $ in Thousands | Jun. 27, 2020 | Jun. 29, 2019 |
Forward Contracts & swaps | Other Current Assets | ||
Derivative Instruments [Line Items] | ||
Derivative Asset, Asset Fair Value | $ 0 | $ 2,912 |
Forward Contracts & swaps | Other Long-Term Assets | ||
Derivative Instruments [Line Items] | ||
Derivative Asset, Asset Fair Value | 1,097 | 320 |
Forward Contracts & swaps | Other Current Liabilities | ||
Derivative Instruments [Line Items] | ||
Derivative Liability, Liability Fair Value | 1,960 | 0 |
Forward Contracts & swaps | Other Long-Term Liabilities | ||
Derivative Instruments [Line Items] | ||
Derivative Liability, Liability Fair Value | 17 | 0 |
Interest Rate Swap | Other Current Assets | ||
Derivative Instruments [Line Items] | ||
Derivative Asset, Asset Fair Value | 0 | 2 |
Interest Rate Swap | Other Current Liabilities | ||
Derivative Instruments [Line Items] | ||
Derivative Liability, Liability Fair Value | 347 | 0 |
Interest Rate Swap | Other Long-Term Liabilities | ||
Derivative Instruments [Line Items] | ||
Derivative Liability, Liability Fair Value | $ 610 | $ 0 |
Derivative Financial Instrume_5
Derivative Financial Instruments (Gain (Loss) Of Derivative Instruments In Statement Of Operations) (Detail) - Designated as Hedging Instrument number in Thousands, $ in Thousands | 12 Months Ended | |||
Jun. 27, 2020USD ($) | Jun. 29, 2019USD ($) | Jun. 30, 2018USD ($) | Jul. 01, 2017USD ($) | |
Derivatives used in Net Investment Hedge, Net of Tax [Roll Forward] | ||||
AOCI Balance | $ (1,500) | $ 2,426 | $ (969) | $ (2,775) |
Derivative Instruments, Gain (Loss) Effective Portion Recorded in AOCI | (1,647) | 3,334 | (1,922) | |
Tax rate effect reclassification | $ (586) | |||
Effective Portion Recorded In AOCI | $ (2,279) | $ 61 | 4,314 | |
Forward Contracts & swaps | ||||
Derivatives used in Net Investment Hedge, Net of Tax [Roll Forward] | ||||
AOCI Balance | $ (759) | $ 2,424 | $ (988) | (2,707) |
Derivative Instruments, Gain (Loss) Effective Portion Recorded in AOCI | (865) | 3,332 | (1,942) | |
Tax rate effect reclassification | $ (583) | |||
Effective Portion Recorded In AOCI | $ (2,318) | $ 80 | 4,244 | |
Interest Rate Swap | ||||
Derivatives used in Net Investment Hedge, Net of Tax [Roll Forward] | ||||
AOCI Balance | $ (741) | $ 2 | $ 19 | $ (68) |
Change in Unrealized Gain (Loss) on Foreign Currency | (782) | 2 | 20 | |
Tax rate effect reclassification | $ (3) | |||
Effective Portion Recorded In AOCI | $ 39 | $ (19) | $ 70 |
Fair Value Measurements (Assets
Fair Value Measurements (Assets And Liabilities Measured At Fair Value On Recurring Basis) (Detail) - Recurring - USD ($) $ in Thousands | Jun. 27, 2020 | Jun. 29, 2019 |
Level 1 | ||
Fair Value Disclosures [Line Items] | ||
Foreign currency forward contracts, Financial Liabilities | $ 0 | |
Level 2 | ||
Fair Value Disclosures [Line Items] | ||
Foreign currency forward contracts, Financial Liabilities | 957 | |
Level 3 | ||
Fair Value Disclosures [Line Items] | ||
Foreign currency forward contracts, Financial Liabilities | 0 | |
Interest Rate Swap | ||
Fair Value Disclosures [Line Items] | ||
Assets, Fair Value Disclosure | $ 2 | |
Foreign currency forward contracts, Financial Liabilities | 957 | |
Interest Rate Swap | Level 1 | ||
Fair Value Disclosures [Line Items] | ||
Assets, Fair Value Disclosure | 0 | |
Interest Rate Swap | Level 2 | ||
Fair Value Disclosures [Line Items] | ||
Assets, Fair Value Disclosure | 2 | |
Interest Rate Swap | Level 3 | ||
Fair Value Disclosures [Line Items] | ||
Assets, Fair Value Disclosure | 0 | |
Forward Contracts & swaps | ||
Fair Value Disclosures [Line Items] | ||
Assets, Fair Value Disclosure | 1,097 | 3,232 |
Foreign currency forward contracts, Financial Liabilities | (1,977) | |
Forward Contracts & swaps | Level 1 | ||
Fair Value Disclosures [Line Items] | ||
Assets, Fair Value Disclosure | 0 | 0 |
Foreign currency forward contracts, Financial Liabilities | 0 | |
Forward Contracts & swaps | Level 2 | ||
Fair Value Disclosures [Line Items] | ||
Assets, Fair Value Disclosure | 1,097 | 3,232 |
Foreign currency forward contracts, Financial Liabilities | (1,977) | |
Forward Contracts & swaps | Level 3 | ||
Fair Value Disclosures [Line Items] | ||
Assets, Fair Value Disclosure | 0 | $ 0 |
Foreign currency forward contracts, Financial Liabilities | $ 0 |
Enterprise Wide Disclosures (Na
Enterprise Wide Disclosures (Narrative) (Detail) - USD ($) | 3 Months Ended | 12 Months Ended | |||||||||
Jun. 27, 2020 | Mar. 28, 2020 | Dec. 28, 2019 | Sep. 28, 2019 | Jun. 29, 2019 | Mar. 30, 2019 | Dec. 29, 2018 | Sep. 29, 2018 | Jun. 27, 2020 | Jun. 29, 2019 | Jun. 30, 2018 | |
Segment Reporting Information [Line Items] | |||||||||||
Revenues | $ 116,018,000 | $ 111,455,000 | $ 116,722,000 | $ 105,285,000 | $ 105,581,000 | $ 107,954,000 | $ 123,037,000 | $ 127,472,000 | $ 449,480,000 | $ 464,044,000 | $ 446,322,000 |
Percentage Of Net Sales | 100.00% | 100.00% | 100.00% | ||||||||
Key Tronic E M S | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Revenues | $ 449,500,000 | $ 463,900,000 | $ 445,800,000 | ||||||||
Keyboard | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Revenues | $ 4,000 | $ 100,000 | $ 500,000 |
Enterprise-Wide Disclosures (Ne
Enterprise-Wide Disclosures (Net Sales And Long-Lived Assets (Property, Plant, And Equipment) By Geographic Area) (Detail) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||||
Jun. 27, 2020 | Mar. 28, 2020 | Dec. 28, 2019 | Sep. 28, 2019 | Jun. 29, 2019 | Mar. 30, 2019 | Dec. 29, 2018 | Sep. 29, 2018 | Jun. 27, 2020 | Jun. 29, 2019 | Jun. 30, 2018 | |
Segment Reporting Information [Line Items] | |||||||||||
Revenues | $ 116,018 | $ 111,455 | $ 116,722 | $ 105,285 | $ 105,581 | $ 107,954 | $ 123,037 | $ 127,472 | $ 449,480 | $ 464,044 | $ 446,322 |
Long-lived assets | 31,764 | 29,413 | 31,764 | 29,413 | 27,548 | ||||||
Domestic (U.S.) | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Revenues | 338,766 | 357,341 | 329,230 | ||||||||
Long-lived assets | 9,213 | 9,658 | 9,213 | 9,658 | 7,454 | ||||||
Foreign | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Revenues | 110,714 | 106,703 | 117,092 | ||||||||
Mexico | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Long-lived assets | 19,325 | 17,781 | 19,325 | 17,781 | 19,395 | ||||||
Vietnam | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Long-lived assets | 2,644 | 1,220 | 2,644 | 1,220 | 0 | ||||||
China | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Long-lived assets | $ 582 | $ 754 | $ 582 | $ 754 | $ 699 |
Enterprise-Wide Disclosures Sch
Enterprise-Wide Disclosures Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area (Detail) | 12 Months Ended | ||
Jun. 27, 2020 | Jun. 29, 2019 | Jun. 30, 2018 | |
Segment Reporting Information [Line Items] | |||
Percentage Of Net Sales | 100.00% | 100.00% | 100.00% |
Domestic (U.S.) | |||
Segment Reporting Information [Line Items] | |||
Percentage Of Net Sales | 75.00% | 77.00% | 74.00% |
China | |||
Segment Reporting Information [Line Items] | |||
Percentage Of Net Sales | 19.00% | 19.00% | 24.00% |
Canada | |||
Segment Reporting Information [Line Items] | |||
Percentage Of Net Sales | 1.00% | 1.00% | 0.00% |
Foreign | |||
Segment Reporting Information [Line Items] | |||
Percentage Of Net Sales | 5.00% | 3.00% | 2.00% |
Enterprise-Wide Disclosures (Pe
Enterprise-Wide Disclosures (Percentage Of Net Sales To And Trade Accounts Receivables From Significant Customers) (Detail) | 12 Months Ended | ||
Jun. 27, 2020 | Jun. 29, 2019 | Jun. 30, 2018 | |
Customer A [Member] | |||
Segment Reporting Information [Line Items] | |||
Percent of Net Sales | 18.00% | 17.00% | 19.00% |
Percentage of Trade Accounts Receivable | 14.00% | 11.00% | |
Customer B [Member] | |||
Segment Reporting Information [Line Items] | |||
Percentage of Trade Accounts Receivable | 12.00% |
Quarterly Financial Data (Detai
Quarterly Financial Data (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||||
Jun. 27, 2020 | Mar. 28, 2020 | Dec. 28, 2019 | Sep. 28, 2019 | Jun. 29, 2019 | Mar. 30, 2019 | Dec. 29, 2018 | Sep. 29, 2018 | Jun. 27, 2020 | Jun. 29, 2019 | Jun. 30, 2018 | |
Quarterly Financial Information Disclosure [Abstract] | |||||||||||
Gross profit | $ 8,606 | $ 9,248 | $ 8,122 | $ 9,273 | $ 8,381 | $ 6,807 | $ 9,880 | $ 9,533 | $ 35,249 | $ 34,601 | $ 34,169 |
Income before income taxes | 506 | 1,010 | 974 | 1,829 | 732 | (13,256) | 1,916 | 1,868 | 4,319 | (8,740) | (1,442) |
Net income (loss) | $ 1,472 | $ 910 | $ 824 | $ 1,552 | $ 817 | $ (11,981) | $ 1,589 | $ 1,593 | $ 4,758 | $ (7,982) | $ (1,325) |
Earnings per share – basic (in dollars per share) | $ 0.14 | $ 0.08 | $ 0.08 | $ 0.14 | $ 0.08 | $ (1.11) | $ 0.15 | $ 0.15 | $ 0.44 | $ (0.74) | $ (0.12) |
Earnings per share – diluted (in dollars per share) | $ 0.14 | $ 0.08 | $ 0.08 | $ 0.14 | $ 0.08 | $ (1.11) | $ 0.15 | $ 0.15 | $ 0.44 | $ (0.74) | $ (0.12) |
Weighted average shares outstanding– basic | 10,760 | 10,760 | 10,760 | 10,760 | 10,760 | 10,760 | 10,760 | 10,760 | 10,760 | 10,760 | 10,760 |
Weighted average shares outstanding — Diluted | 10,832 | 10,885 | 10,877 | 10,805 | 10,760 | 10,760 | 10,881 | 10,979 | 10,816 | 10,760 | 10,760 |
Revenues | $ 116,018 | $ 111,455 | $ 116,722 | $ 105,285 | $ 105,581 | $ 107,954 | $ 123,037 | $ 127,472 | $ 449,480 | $ 464,044 | $ 446,322 |
Goodwill and Other Intangible_2
Goodwill and Other Intangible Assets (Narrative) (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 27, 2020 | Jun. 29, 2019 | Jun. 30, 2018 | |
Goodwill [Line Items] | |||
Goodwill, Impairment Loss | $ 10,000 | ||
Impairment of Intangible Assets, Finite-lived | (2,492) | ||
Amortization of Intangible Assets | 600 | $ 1,100 | |
Derecognition Favorable Lease per ASC 842 | $ (700) | ||
Finite-Lived Intangible Assets, Net | 0 | 657 | |
Non-Compete Agreements | |||
Goodwill [Line Items] | |||
Impairment of Intangible Assets, Finite-lived | 0 | ||
Finite-Lived Intangible Assets, Net | 0 | ||
Customer Relationships | |||
Goodwill [Line Items] | |||
Impairment of Intangible Assets, Finite-lived | (2,492) | ||
Finite-Lived Intangible Assets, Net | 0 | ||
Favorable Lease Agreements | |||
Goodwill [Line Items] | |||
Impairment of Intangible Assets, Finite-lived | 0 | ||
Derecognition Favorable Lease per ASC 842 | (657) | ||
Finite-Lived Intangible Assets, Net | $ 0 | $ 657 |
Schedule of Finite-Lived Intang
Schedule of Finite-Lived Intangible Assets (Detail) - USD ($) $ in Thousands | 12 Months Ended | |
Jun. 27, 2020 | Jun. 29, 2019 | |
Finite-Lived Intangible Assets [Line Items] | ||
Finite-Lived Intangible Assets, Gross | $ 2,941 | $ 8,312 |
Finite-Lived Intangible Assets, Accumulated Amortization | (2,284) | (5,163) |
Derecognition Favorable Lease per ASC 842 | (700) | |
Impairment of Intangible Assets, Finite-lived | 2,492 | |
Finite-Lived Intangible Assets, Net | $ 0 | 657 |
Non-Compete Agreements | ||
Finite-Lived Intangible Assets [Line Items] | ||
Finite-Lived Intangible Assets, Gross | 568 | |
Finite-Lived Intangible Assets, Accumulated Amortization | (568) | |
Impairment of Intangible Assets, Finite-lived | 0 | |
Finite-Lived Intangible Assets, Net | $ 0 | |
Non-Compete Agreements | Minimum | ||
Finite-Lived Intangible Assets [Line Items] | ||
Finite-Lived Intangible Asset, Useful Life | 3 years | |
Non-Compete Agreements | Maximum | ||
Finite-Lived Intangible Assets [Line Items] | ||
Finite-Lived Intangible Asset, Useful Life | 5 years | |
Customer Relationships | ||
Finite-Lived Intangible Assets [Line Items] | ||
Finite-Lived Intangible Asset, Useful Life | 10 years | |
Finite-Lived Intangible Assets, Gross | $ 4,803 | |
Finite-Lived Intangible Assets, Accumulated Amortization | (2,311) | |
Impairment of Intangible Assets, Finite-lived | 2,492 | |
Finite-Lived Intangible Assets, Net | 0 | |
Favorable Lease Agreements | ||
Finite-Lived Intangible Assets [Line Items] | ||
Finite-Lived Intangible Assets, Gross | $ 2,941 | 2,941 |
Finite-Lived Intangible Assets, Accumulated Amortization | (2,284) | (2,284) |
Derecognition Favorable Lease per ASC 842 | (657) | |
Impairment of Intangible Assets, Finite-lived | 0 | |
Finite-Lived Intangible Assets, Net | $ 0 | $ 657 |
Favorable Lease Agreements | Minimum | ||
Finite-Lived Intangible Assets [Line Items] | ||
Finite-Lived Intangible Asset, Useful Life | 4 years | |
Favorable Lease Agreements | Maximum | ||
Finite-Lived Intangible Assets [Line Items] | ||
Finite-Lived Intangible Asset, Useful Life | 7 years |
Revenue (Detail)
Revenue (Detail) - USD ($) $ in Thousands | 12 Months Ended | |||
Jun. 27, 2020 | Jun. 29, 2019 | Jun. 27, 2020 | Jul. 01, 2018 | |
Disaggregation of Revenue [Line Items] | ||||
Beginning balance, June 29, 2019 | $ 22,161 | $ 0 | ||
Contract with Customer, Asset, Cumulative Catch-up Adjustment to Revenue, Change in Measure of Progress | 11,906 | |||
Revenue recognized | 441,405 | 448,003 | ||
Amounts collected or invoiced | (439,813) | (437,748) | ||
Contract assets | $ 22,161 | $ 0 | $ 23,753 | $ 11,906 |
Revenue (Disaggregation of Reve
Revenue (Disaggregation of Revenue) (Detail) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||||
Jun. 27, 2020 | Mar. 28, 2020 | Dec. 28, 2019 | Sep. 28, 2019 | Jun. 29, 2019 | Mar. 30, 2019 | Dec. 29, 2018 | Sep. 29, 2018 | Jun. 27, 2020 | Jun. 29, 2019 | Jun. 30, 2018 | |
Disaggregation of Revenue [Line Items] | |||||||||||
Revenues | $ 116,018 | $ 111,455 | $ 116,722 | $ 105,285 | $ 105,581 | $ 107,954 | $ 123,037 | $ 127,472 | $ 449,480 | $ 464,044 | $ 446,322 |
Transferred over Time [Member] | |||||||||||
Disaggregation of Revenue [Line Items] | |||||||||||
Revenues | 441,405 | 458,256 | |||||||||
Transferred at Point in Time [Member] | |||||||||||
Disaggregation of Revenue [Line Items] | |||||||||||
Revenues | $ 8,075 | $ 5,788 |
Leases (Detail)
Leases (Detail) | 12 Months Ended |
Jun. 27, 2020USD ($) | |
Lessee, Lease, Description [Line Items] | |
Lease, Cost | $ 5,777,000 |
Cost of Sales | |
Lessee, Lease, Description [Line Items] | |
Operating Lease, Cost | 4,511,000 |
Selling, General and Administrative Expenses | |
Lessee, Lease, Description [Line Items] | |
Operating Lease, Cost | $ 1,266,000 |
Maximum | |
Lessee, Lease, Description [Line Items] | |
Lessee, Operating Lease, Term of Contract | 11 years |
Minimum | |
Lessee, Lease, Description [Line Items] | |
Lessee, Operating Lease, Term of Contract | 1 year |
Assets and Liabilities, Lessee
Assets and Liabilities, Lessee (Detail) - USD ($) | 12 Months Ended | ||||
Jun. 27, 2020 | Mar. 28, 2020 | Dec. 28, 2019 | Sep. 28, 2019 | Jun. 29, 2019 | |
Lessee, Lease, Description [Line Items] | |||||
Operating Lease, Right-of-Use Asset | $ 17,568,000 | $ 18,474 | $ 19,099 | $ 20,279 | $ 0 |
Total lease liabilities | $ 17,173,000 | ||||
Operating Lease, Weighted Average Remaining Lease Term | 6 years 5 months 15 days | ||||
Operating Lease, Weighted Average Discount Rate, Percent | 4.07% | ||||
Operating Lease, Liability, Current | $ 4,500,000 | ||||
Operating lease liabilities | 12,624,000 | $ 13,454 | $ 14,093 | $ 15,108 | $ 0 |
Operating Lease, Payments |
Lessee, Operating Lease, Liabil
Lessee, Operating Lease, Liability, Maturity (Detail) - USD ($) | Jun. 27, 2020 | Jun. 29, 2019 |
Leases [Abstract] | ||
2021 | $ 4,250,000 | |
2022 | 3,373,000 | |
2023 | 2,598,000 | |
2024 | 2,004,000 | |
2025 | 1,894,000 | |
Thereafter | 5,674,000 | $ 4,121,000 |
Total undiscounted lease payments | 19,793,000 | $ 18,239,000 |
Less: present value discount | 2,620,000 | |
Total lease liabilities | $ 17,173,000 |
Schedule of Future Minimum Rent
Schedule of Future Minimum Rental Payments for Operating Leases (Detail) - USD ($) $ in Thousands | Jun. 27, 2020 | Jun. 29, 2019 |
Leases [Abstract] | ||
2020 | $ 4,777 | |
2021 | 3,563 | |
2022 | 2,641 | |
2023 | 1,866 | |
2024 | 1,271 | |
Thereafter | $ 5,674 | 4,121 |
Total undiscounted lease payments | $ 19,793 | $ 18,239 |
LEASES (Details)
LEASES (Details) - USD ($) | Jun. 27, 2020 | Mar. 28, 2020 | Dec. 28, 2019 | Sep. 28, 2019 | Jun. 29, 2019 |
Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||||
Operating Lease, Right-of-Use Asset | $ 17,568,000 | $ 18,474 | $ 19,099 | $ 20,279 | $ 0 |
Total assets | 304,861,000 | 291,530 | 278,193 | 285,350 | 238,310,000 |
Operating lease liabilities | 12,624,000 | 13,454 | 14,093 | 15,108 | 0 |
Total long-term liabilities | $ 77,085,000 | 178,590 | 161,386 | 170,212 | $ 30,447,000 |
Revision of Prior Period, Adjustment | |||||
Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||||
Operating Lease, Right-of-Use Asset | 3,127 | 4,223 | 4,223 | ||
Total assets | 3,127 | 4,223 | 4,223 | ||
Operating lease liabilities | 3,127 | 4,223 | 4,223 | ||
Total long-term liabilities | 3,127 | 4,223 | 4,223 | ||
Previously Reported | |||||
Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||||
Operating Lease, Right-of-Use Asset | 15,347 | 14,876 | 16,056 | ||
Total assets | 288,403 | 273,970 | 281,127 | ||
Operating lease liabilities | 10,327 | 9,870 | 10,885 | ||
Total long-term liabilities | $ 175,463 | $ 157,163 | $ 165,989 |
Subsequent Event (Detail)
Subsequent Event (Detail) - USD ($) | 12 Months Ended | |||
Jun. 27, 2020 | Sep. 05, 2019 | Jun. 29, 2019 | Sep. 29, 2018 | |
Subsequent Event [Line Items] | ||||
Debt Instrument, Basis Spread on Variable Rate | 2.00% | |||
Long-term Debt | $ 70,935,000 | $ 5,000,000 | $ 35,000,000 | |
Long-term Debt | ||||
Subsequent Event [Line Items] | ||||
Long-term Debt | $ 10,000,000 | $ 11,300,000 |
Schedule II (Consolidated Valua
Schedule II (Consolidated Valuation And Qualifying Accounts) (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 27, 2020 | Jun. 29, 2019 | Jun. 30, 2018 | |
Provision for obsolete inventory | |||
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] | |||
Balance at beginning of year | $ 1,792 | $ 1,458 | $ 1,306 |
Provisions | 136 | 91 | 31 |
Dispositions | 40 | 243 | 121 |
Balance at end of year | 1,968 | 1,792 | 1,458 |
Allowance for Doubtful Accounts | |||
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] | |||
Balance at beginning of year | 58 | 0 | 84 |
Provisions | 551 | 58 | (84) |
Dispositions | 0 | 0 | 0 |
Balance at end of year | $ 609 | $ 58 | $ 0 |